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IfrTRODUCnON 
Ectopic protein# 
Oncogen##i# i# cb#r#ct#riz#d by cellular chang## such as 
unregulated cell growth, alterations in the pUsma membrane composition, 
cytoskeletal rearrangements, and changes in the activity of genes 
(Becker, 1975: Cameron and Pool, 1981; Ruddon, 1981; Sherbert, 1982). A 
change frequently accompanying neoplasia is the production of ectopic 
proteins. Ectopic proteins sre gene products which are not 
characteristic of the cell type from which the tumor was derived. 
Ectopic proteins are produced both by tumors in vivo and by continuous 
cell lines derived fro# such tumors (Bower and Gordan, 1965; Upsett, 
1965; Liddle et al., 1969). Proteins which have been reported as 
ectopic tmor products include vssopressin (Klein et al., 1969), growth 
hormone (GreenWrg et al., 1972), human chorimiie gonadotropin (Rabson 
et al., 1973) calcitonin (Lunsden et al., 1980), parathyroid hormone 
(Oremberg et al., 1973), human placental lactogen (Rabson et al., 
1973), alpha-fetoproteia (Abelev et al., 1967), carcinoembryonic antigen 
(Gold and Freedman, 1965), placental alkaline phosphatase (Stolbach et 
al., 1969), ACTH (Wddle et al., 1962), and isoferritins (Drysdale and 
Singer. 1974). Although tumor-dependent synthesis of these proteins has 
not always been rigorously demonstrated, the evidence for this 
phenomenon is strmg which suggests that it may be a general feature of 
oec^ lasia (Odell et al., 1977; Bower and Gordan, 1965). 
2 
While ectopic protein synthesis may be common to neoplasia, it is 
not a random event, and particular ectopic proteins tend to be 
associated with specific tumors (Aszopardi and Williams, 1968; Rosen et 
al., 1980). For example, ACTH production is often associated with oat 
cell carcinoma of the bronchus snd parathyroid hormone (PTH) with 
squamous cell carcinoma. Also, certain ectopic hormones tend to be 
produced together (e.g., oxytocin and arginine vasopressin), suggesting 
that their expression may be co-ordinately regulated. 
Ectopic proteins are very similar to their normal counterparts in 
structure and function. However, differences in isoelectric points, 
•lectrophorecic mobility, and carbohydrate content indicate that they 
are not identical (Ueintraub et al., 1975; Orth et al., 1973; Neuwald 
and Brooks, 1981). Many ectopic hormones are biologically active and 
result in clinical syndromes characteristic of aberrant hormone 
production such as Cushing's syndrome (ectopic ACTH), hypercalcemia 
(parathyroid hormone), and gynecomastia (gonadotropin). Enhanced 
hormone production may also arise from ttnwrs of endocrine glands, in 
which case, synthesis is eutopic. It is Important to be able to 
distinguish between the paraneoplastic effects of ectopic hormone 
production and production due to endocrine gland dysfunction. In at 
least three cases, extirpation of the normal endocrine gland was 
performed because the initial diagnosis was Incorrect (Scholz et al., 
1973; Mattingly et al., 1964; Mason et al., 1972). The study of ectopic 
proteins may reveal differences with the normal product to aid 
diagnosis. 
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Goldstein «c al. (1980) have observed the presence of PAP activity 
in the endocervix and cervical mucosa of non-pregnant women with no 
evidence of malignancy. This report raises the question of whether 
cervical tumor PAP activity (e.g. HeLa) is truly ectopic. Nevertheless, 
PAP activity has been observed in association with a number of different 
types of cancer (Fishman et al., 1968; Mathanson and Pishman, 1971; 
Ghosh et al., 1972; Rosen et al., 1975). Fetal intestinal alkaline 
phosphatase has also been found in a number of tumors (Suzuki et al., 
1975; Higashino et al., 1977). 
Similarly, low levels of h(Xï have been observed in normal tissues 
other than placenta (Yoshimoto et al., 1977). In contrast to the 
placental hormone, material from liver and colon extracts seemed to 
contain little or no carbohydrate as determined by chromatography on Con 
A coupled to agarose. In addition, hCC was observed to have a low 
carbohydrate content in tumors where production was low and a high 
carbohydrate content in tumors with high production (Yoshimoto et al., 
1979). These results were interpreted to indicate that the peptide 
sequence of bCG could be synthesized by both normal and neoplastic 
tissues and that the rate of ectopic hormone production may result from 
concomitant high rates of glycosylation. 
Despite this possible ambiguity, measurement of ectopic protein 
levels in the circulation of patients may be used in the diagnosis of 
cancer as well as to monitor the effectiveness of therapy to eradicate 
the tumor. That is, if the synthesis of the protein is indeed tumor* 
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dependant, then the circulatin# levels should cortespcnd with the growth 
or regression of the tumor. Thus, the study of ectopic proteins is 
significant because of their role in the biology, pathology, and 
treatment of tumors. Also, the study of factors affecting the 
production of these proteins may elucidate important regulatory events. 
Human chorionic sonadotropin 
This study examines the production of human chorionic gonadotropin 
(hC8) and placental alkaline phosphatase (PAP) in human cervical 
carcinooa (Hela) cell lines; hence, a brief description of each of these 
proteins will be presented. 
Kuman chorimic gonadotropin is s glycoprotein hormone synthesized 
primarily by t^  syncytioecophoblast cells during pregnancy. It 
functions in the maintenance of the corpus luteim and may also promote 
gonadal development in the fetus. 
The glycoprotein hormones hCS. TSH, IH, and F8H comprise a family 
of proteins which are composed of two non-identical subunits designated 
8 and B. The a subunit is the same for all of these hormones while the 
B subunit is unique and cmveys the biological activity of each hormone. 
The structure of hCG has been studied by a number of groups (Bell et 
al., 1969; Bahl, 1969a; Bahl. 1969b; Hers et al., 1974). The alpha 
subunit of hC6 (hC6*a) has a of about 14,900 while the beta subunit 
(hCG-B) has a of about 23,000 as computW from the chemical 
composition (Bellisario et al., 1973; Carlsen et al., 1973). Both 
subunits are about 30% by weight carbohydrate which is linked to either 
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•sparagifl* or sarin* rasiduaa. Tha amino acid aaquanca (Balliaario at 
al., 1973; Carlaan ae al., 1973; Morgan at al., 1975} and tha 
carbohydrata structuras (Bahl, 1969b; Kannady and Chaplin, 1976; Endo at 
al., 1979) of both subunits hava baan datarminad. 
Tha glycoaylatiqn and aacration of hCG and its subunits has baan 
atudiad by Ruddon at al. (1979a; 1979b; 1980; 1981) in tha JAR (a 
choriocarcinoma), ChaGo (a broncoganic carcinoma), and KaLa call Unas. 
Tha hC6-a aubunit haa intarmadiata glycosylatad foras with of IS,000 
and 18,000 and a of 22,000 for tha matura form as datarminad by SOS-
polyacrylamida gal alactrophoraais. Tha glycosylatad intarmadiataa of 
hCC-6 hava of 16,000 and 24.000 whila tha matura protain has a of 
34,000. Tha rata limiting stap in tha glycosylation of hC6 in JAR calls 
may involva tha action of o-mannosidasa(s) (Ruddon at al., 1981) with 
tarminal glycosylation and aacratiw occurring rapidly tharaaftar. 
Tha production of hCC has baan datactad in tha sarum of patiants 
with a variaty of timers (Navilla, 1982) as wall as a numbar of tumor 
call linas (Ghosh and Co%, 1976; Xanabus at al., 1978; Komfald and 
Komfald, 1976; Rabaon at al., 1973; Tashjian at al., 1973). Synthasis 
of hCG is autopic if tha call lina was darivad from a trophoblastic 
tumor, such as JAR choriocarcinoma cells, and ectopic if the cell line 
was derived from non-trophoblastic tumors such as ChaGo broncogenic 
carcinoma cells and HeLa cervical carcinoma cells. 
The synthesis of hCG subunits is often unbalanced ^  vivo 
(Vaitukaitis et al., 1976; Veintraub and Rosen, 1973; Rosen and 
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Vcintrtub, 1974) «s well is in vitro (Teshjiin et #1., 1973; Chou et 
ml., 1977; Ruddon et al, 1979b) with hCG-a production frequently in 
excess of hCG-@. During pregn&icy, excess hCO-a is synthesized and the 
amount of hCG-P becomes the limit *jxg factor in the production of holo-
hCG (Vaitukaitis et al., 1976). This unbalanced synthesis of hCG and 
its subunits during pregnancy can be accoimted for by the steady state 
levels of the corresponding mANAs (Boo^ hby et al., 1983). 
Recently, the mRNAs encoding both hCG-a and hCQ-9 have been 
isolated and utilized to synthesize and clone cDNAs for both subunits 
(landsfeld et si., 1976; Daniels-McQueen et al., 1978; Fiddes and 
Goodman, 1979; Fiddes and Goodman, 1980; Boothby et al., 1981). Frt» 
human-mouse hybrid cells it has been determined that two human 
chroMsomes are require* for intact hCG production (BordeIon-Riser ec 
al., 1979; Kohler et al., 1980). The common glycoprotein subunit 
appears to be encoded by s single gene (Bootbby et al., 1981; Fiddes and 
Goodman, 1981) apparently on chromosome 18 (Hardin et al., 1983), while 
th# hCG-S subunit may be «coded by a miaimiMi of eight genes (Boorstein 
ee al., 1982). Tha numbar of apparent hCG-g genes may reflect the 
degree of sequence homology among the various genes coding for the 
# 
different glycoprotein beta subunits. 
Placental alkaline phosphatase 
Alkaline phosphatases are a group of enzymes which catalyze the 
hydrolysis of monophosphate esters at alkaline pH optima. Human 
alkaline phosphatase consists of isozymes characteristic of specific 
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tissues and dsvsloposntal stages. Thssa isosynas art naobrana bound 
glyeopcotains which can ba diffarantiatad by thair alactrophoratic 
mobility (Harris and Hopkinson, 1976; Robinson and Plarca, 1964), 
tharmostability (Naala at al., 1965; Moss at al., 1972; Patit-Clarc, 
1976), sansitivity to L-isino acids (Hulivor at al., 1978b), and by 
Immunological oathods (Boyar, 1963; Susaman at al., 1968; Komoda and 
Sakagishi, 1976; McKanna at al., 1979). 
Tha various human Isosymas appaar to ba ancodad by at laast thraa 
structural ganas: w tor tha placantsl Isosyna, ona for tha intestinal 
isosyaa, and ona for tha bona, livar, and kidnay isosymas (or tissue 
non-specific isosyma). Severs1 electrophoretic variants of PAP have 
been shown to ba alleles of an autosomal locus (Robson and Harris, 
1967). The other isozymes do not exhibit such variants and are 
presumably detenmined by another locus or loci (Harris and Hopkinson, 
1976). Also, the autosomal recessive disease of hypophosphatasia 
results in depressed activity of liver, bone, and kidney alkaline 
phosphatases but does iwt affect intestinal or placental alkaline 
phMphacosa (Fraser, 1957; Danoviecb ec al., 1968; Mulivor ee al., 
1978c). Furthermore, txyptic peptide maps of the purified isozymes are 
similar for bone, liver, and kidney alkaline phosphatases yet 
distinguishable fro# intestinal and placental which are themselves 
distinct fro# each other (Badger and Sussman, 1976; McKanna at al., 
1979; Seargeant and Stinson, 1978). Finally, inhibition studies with a 
variety of L-aaino acids yields identical profiles for liver, bone, and 
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kidney isosyms but different profiles for placental and intestinal, 
which are distinct from each other (Mulivor et al., 1978a). 
Alkaline phosphatase isolated from the first trimester placenta 
(chorionic PAP) differs from the term placental alkaline phosphatase 
(PAP) in its thermostability and sensitivity to L-homoarginine and L-
phenylalanine (Piahman et al., 1976). A similar developmental differ­
ence exists between fetal and adult intestinal alkaline phosphatase, but 
not with fetal and adult liver, bone, or kidney (Mulivor et al.* 1978a). 
The term placental isosyme of alkaline phosphatase is expressed by 
several tumor cell lines (Elson and Cox, 1969; Bechuan et.al., 1970; 
iuduena and Sussman, 1976; Benha» ec al., 1978; Rnilton et al.. 1979a). 
In addition, some KeLa cell lines synthesize an isoeym# more closely 
resembling the chorionic PAP or intestinal isozymes in its 
thermostability (BenhM et al., 1978; Benham and Harris. 1979). Various 
differences in the physicochemical properties have been observed between 
the tumor associated PAP and normal PAP (Neuwald and Brooks, 1981). 
Recently, the biosynthesis and processing of PAP has been examined 
in choriocarcinoma cells (Zco and Chou, 1983). Apparent molecular 
weights of 61,500 and 64,500 were estimated for the precursor and fully 
glycosylated forms of the PAP monomer synthesized in vivo. The 
unglycosylated monomer has an apparent of 58.000. Also, a preprocein 
with M of 60.000 was observed bv in vitro translatif* of 
r "*"• —• 
choriocarcinoma aiRNA in the absence of membranes. 
.9 
Induction of Ectopic Protein* by Sodium Butyrate 
Butyric acid or its sodium salt has multiple effects on a variety 
of cells (Prasad and Sinha, 1976; Kruh, 1982). These effects include 
the inhibition of cell growth and ONA synthesis (Wright, 1973; Riggs ec 
al., 1977; Kagopian et al., 1977), alterations in cell morphology 
(Ginsburg et al., 1973; Oeutsch et al., 1976; Aleenburg et al., 1976; 
Mori ee al., 1979; Borenfretmd et al., 1980), modifications of nuclear 
proteins (Riggs et al., 1977; Vidali et al., 1978; Boffa et al., 1981), 
and changes in many protein and eneym# levels (Griffen et al., 1974; 
Chou and Robinson, 1977b; Fishman et al., 1974; Ghosh and Cox, 1976). 
Most of these alterations are freely reversible within 24 hours after 
rMOval of btttyrate from the culture medium. 
Heia cells are normally round or polygonal in appearance and have a 
doubling time of about 24 hours. Recently, it has been shown that 
btttyrate at mM concentrations arrests HeLa cell growth primarily at the 
61/8 border and also in the 62 portion of the cell cycle (Fallon and 
Cm, 1979). Arrest of cell growth in 61 has also been observed in other 
cell types (Rastl and Swetly, 1979; D'Anna et al., 1980b). Inhibition 
of cell growth ie accompanied by the appearance of filamentous 
protrusions 7 to 8 hours after butyrate exposure, which develop into ' 
long spikes by 12 hours (Ginsburg et al., 1973). Electron micrographs 
of cells grown in the presence of butyrate show corresponding changes in 
ultrastructural components. For exaa^ le, in virally transformed rat 
kidney cells exposed to butyrate, the assembly of cytoplasmic 
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oicrofilaaants and aicxotubulas along with tha formation of substrata 
adhasiva plaquas and intareallular gap Junctions ara obsarvad (Altanburg 
at al., 1976). Also, tha addition of butyrata to chemically transformad 
rat hepatoma calls results in intermediate filaments which resemble 
normal filaments in their organisation (Borenfreund et al., 1979; 
Borenfreund et al., 1980). 
Several changes in plaama membrane components have been aasociated 
with butyrata action. For example, the fatty acid stimulates an 
increase in the levels of glycosphingolipid in HeLa cells by 
elevating aialyltransferase I activity (Fishman at al., 1974; Simmons at 
al., 1975). This increase in aialyltransferase activity precedes the 
formation of cellular protrusions and upon the removal of butyrata, 
aialyltransferase activity dacreaaes prior to the return of normal HeLa 
call morphology (Fishman and Brady, 1976). Modification of membrane 
gangliosides has also barn* observed in transformed rat kidney cells 
treated with butyrata (Via at al., 1980). Another ganglioside, GM^ , is 
the receptor for cholera toxin (Fishman and Brady. 1976; Bennett et al., 
1976; Cuatrecasas, 1973). An increase of this receptor is observed 
after 20 hours of exposure to butyrata in HeLa, rat C6 glial, and Friend 
erythroleukemia calls (Fishman and Atikkan, 1979). Butyrata has a two­
fold, concentration dependent effect on adrenergic receptors in HeLa 
cells. At coneantratims greater than 2 mW, receptor levels are 
induced and functionally coupled to pre-existing adenylate cyclase 
molecules within 10 hours. Ac lower concentrations of butyrata (0.5 to 
Il 
1.0 «M), th« receptor levels ere fully induced but are not functionally 
coupled with adenylate cyclase. A subsequent shift to the higher 
butyrate concentration initiates coupling following a brief 2 hour lag 
(Henneberxy et al., 1977). Recent evidence suggests that butyrate 
induces qualitative changes in the regulatory component of the 
-^adrenergic system (Kassis et al., 1984). 
Sodium butyrate, as well as Cortisol and other compounds, increases 
the activity of PAP in KeLa cells. This increase in activity may result 
fros either an increase in the catalytic efficiency of the enzyme or an 
increase in the biosynthesis of the ensyme. Studies by Ghosh et al. 
(1972) indicate that the PAP activity induced by Cortisol results from 
an increase in the catalytic efficiency due to a decrease in the 
phosphorylatira of the enzyme. Similar interpretations have been given 
for the induction of PAP activity in Hela cells by S-bromodeoxyuridine 
(Bttlmer et al., 1976) and 5-iododeoxyuridine (6os and Walker, 1978). 
However, contrary to these reports, Hanford and Fishman (1983) observe 
an induction in the biosynthesis of PAP in HeW cells by the synthetic 
glucocorticoid prednisolone and butyrate. The increase in the amount of 
PAP is sufficient to account for th# enhanced enzyme activity. 
Furthermore, Hwilton and Sussmaa (1981) and I to and Chou (1984) observe 
that 5"bromodeoxyuridine and butyrate respectively induce the novo 
synthesis of PAP in choriocarcinoma cells. It is unclear if this 
disagreement is due to technical differences or actual differences in 
the Mechanism of induction. 
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In other cell lines which express two isozymes of alkaline 
phosphatase, the placental isoxyme is induced preferentially (Nitowsky 
et al., 1963; Tokualtsu et al., 1979; Hers, 1973; Hamilton et al., 
1979b). Occasionally, however, there is an equal induction of both 
isoaymes (Speeg et al., 1977), and in SW-620 cells (established from a 
human colon carcinoma), butyrate induces the tissue non-specific isozyme 
but not the placental isozyme (Kerz and Halwer, 1983). 
In addition to alkaline phosphatase, butyrste also stimulates the 
production of human chorionic gonadotropin and its a and S subunits in 
various tumor cell lines (Ghosh and Cox, 1976; Lieblich et al., 1976; 
Chou et al., 1977; Ghosh et al., 1977). The amount of hCG-a secreted 
into the medium by HeLa cells is enhanced within 12 hours after the 
addition of butyrate followed by a more dramatic increase after 24 
hours. The production of hCG and hCG-a varies among HeLa cell lines 
with respect to subunit accumulation in the méditas and in the degree of 
induction (Lieblich et al., 1977; Chou, 1978; Cox, 1981c). Thus, 
relative to one another, some HeLa cell lines (2.2 and S-3) are high 
producers (about 70 to 100 ng/mg protein-day) and others are low 
producers (2 and 2.1; 10-30 ng/mg protein-day). The induction of M^ G-a 
by butyrate in HeLa cells also varies with the medium composition (Cox 
and KcClure, 1983). 
While butyrate induces the ectopic synthesis of bCG and hCG-a by 
Qon-trophoblastic tumor cells ((Jhago and HeLa), it does not affect and 
may inhibit synthesis by trophoblastic cells (BeVo, JEG, and Reid 
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choricarcinooM) vhara tha placental horaona is a eutopic product (Chou 
et al., 1977; Kuaaa et al., 1978). Ectopic and eutopic ayntheai# of hC6 
also differs with respect to subunit glycosylation (Ruddon et al., 
1979a; Ruddon et al., 1979b; Ruddon et al., 1980). Only the 
glycosylation intermediates and not the fully processed hC6 accumulates 
intracellularly in JE8 cells. However, the fully processed hCG does 
accumulate intracellularly in ChaGo and butyrate treated KeLa cells. 
Thus, trophoblastic and non-trophoblastic cells may control the 
processing and secretion of hC6 differently. Recently, glycosylation 
was reported to be significant in the butyrate inductim of hCG-o in 
cells (Cox, 1981a; KcClure and Cox, 1984) and Chang human liver 
cells (Morrow et al., 1983). 
Butyrate elicits a variety of responses in hormone mediated 
processes. For example, the estradiol induction of ovalbumin and 
transferrin transcription in chick oviducts is blocked by butyrate and 
other short chain fatty acids (KcJCnight et al., 1980). Butyrate does 
not affect either estradiol binding to its receptor or transport to the 
nucleus. In rat C6 glioma cells, hydrocortisone induces glycerol 
phMphate dehydrogenase (6FDH) and glutamine synthetase (GS), and 
norepinephrine induces lactate dehydrogenase (U)B). Sodium butyrate 
inhibits the hydrocortisone mediated induction of GPDH but not of GS 
or the norepinephrine induction of LOB (Veingarten and de Vellis, 1980; 
Veingarten et al., 1981). Butyrate does not affect the binding of 
hormone to its receptor. In addition, butyrate alone induces GS but not 
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6PDH. Sodium butyrmt# also inhibits th« prolactin induction of casain 
synthasis and caaain oRMA accumulation in rabbit mammary expiants 
(Hartal at al., 1983). In this situation, butyrata inhibits induction 
at tha nambrana laval by blocking tha ganaration of tha prolactin 
intracellular relay from prolactin treated membranes. Samuels et al. 
(1980) have studied the effect of butyrata on the nuclear level of 
glucocorticoid and thyroid hormone receptors in GH^  cells. Butyrata 
decreaaes the thyroid hormone nuclear receptor without affecting total 
protein synthesis. Butyrata did not affect either the total cellular 
level or tha nuclear asaociation of glucocorticoid receptors. In other 
studies, tha carboxylic acid prevented glucocorticoid induction of 
tyrosln# aalnotransfarasa In RIC cells (Tichonlcky et al., 1983), but 
enhanced induction of PAP in Bala cells by tha synthetic glucocorti­
coid daxamathasona, even though tha cytoplasmic receptor was 
dacreaaad by 33% and tha nuclear receptor by 49% (littlefiald at al., 
1980). 
A sigmificast coasaqoanca of butyrata action is tha modification of 
chromatin proteins. Rig## et al. (1977) first reported that butyrata 
induces the hyperacatylation of histones H3 and N4 primarily, and of H2A 
and H2B to a lesser extmt. These modification# result from butyrate's 
non-competitive inhibition ((ïousens et al., 1979) of the histone 
deacetylasa enzymes (Sealy and Chalkley, 1978a; Candido et al., 1978; 
Vidali et al., 1978; Boffa et al., 1978). Hyperacatylation occurs 
within 24 hours after the addition of butyrata and is freely reversible. 
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ActcyUtion of th« c amino group of lys in* rasiduM in eha amino 
carminus of tha hiaconas is thought to waakan tha protain's interaction 
with tha phoaphata groups of tha DNA. An alteration of the chromatin 
structure is indicated by an enhanced accaaaibility of the DMA to DNAse 
I and micrococcal nuclaaaa digeation (Vidali at al., 1978; Simpaon, 
1978; Nelson at al., 1978; Saaly and Chalklay, 1978b) and by an 
incraaaed availability of histone H3 to phosphorylation by a nuclear 
Ca**-dapeadent protein kinase (Whitlock et al., 1980). Several groups 
have correlated enhanced nuclease digestion with potential gene activity 
(Veintraub and Groudine, 1976; Garel et al., 1977; Levy and Dixon, 1977; 
Nelson et al., 1978; Davie et al., 1978). 
However, the role of histone hyperacetylation in transcription is 
unclear. While several reports correlate acetate incorporation into 
histones with ofiNA synthesis (Allfrey et al., 1964; Pogo et al., 1968; 
Dobaon and Ingram, 1980), other investigators observe no effect of 
histone hyperacetylation on the overall rate of in vitro transcriptira 
in isolated nuclei (Moore et al., 1978; Hathis et al., 1978; Lilley and 
Berendt, 1979). Perry and (Hialkley (1982) report that histone 
acetylation increases the solubility of chromatin and that the 
complexity of the WA associated with hyperacetylated nucleosomes is the 
same as the total WfA, indicating that hyperacetylation occurs over both 
active and inactive regions of the WIA. These observations, along with 
those of Recgek et al. (1982), suggest that butyrate may alter higher 
order chromatin structure (intemucleosomal) rather than interactions 
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b«ew««n DMA and cor* histonas (intranuclaosooal). Oliva and Hazquita 
(1982) and Grima# and Handarion (1983) augfaat that hyparacatylatlon of 
H4 may correlate more eloaely to the dlaplacement of nucleohiatonea by 
nucleoprotaaine, which occur# during spermatogeneais, than to general 
tranacriptional activity. 
Prolonged expoaure to butyrate impair# the ability of KTC cell# to 
acetylate histone# (Covault at al., 1982b). When butyrate i# removed, 
the deacetylaae enaqrme# recover more rapidly than the aeatylaaa enzyme# 
reeulting in hypoacetylatad hiatone#. Utilizing theae two acetylation 
atates, Covault ec al. (1982a) obaerved that histone acetylation ha# no 
immediate and direct effect on transcription in the intact cell#. 
However, the rapid acetylation of a small population of hi#tone# may 
play a role in RNA synthesis initiation. 
Butyrate also induces several other modifications of chromatin 
associated proteins. Boffa et al. (1981) examined the effect of 
butyrate on the acetylation, phosphorylation, poly (ADP)-ribosylation, 
and methylstioo of chromosomal proteins in ReLa cells. They report that 
butyrate inhibits the phosphorylation of histones HI and H2A in a 
reversible, concentration, and timm-dependent manner. Phosphorylation 
of non-histono proteins was stimulated, unaffected, or inhibited 
depending iq)on the protein examined. No effect was observed on the poly 
(ADP)-ribosylation of histwes in cells treated with butyrate while 
methylation of histones and proteins associated with hnJUIP particles is 
inhibited. Butyrate also leads to the dephosphorylation of histone HI 
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(D'Anna «c al., 1980a) and an incraastd acitylation of high mobility 
group protains 14, 17, 1, and 2 (Stamar #t al., 1978; Sc«m«r at al., 
1979; Stamar at al., 1981). 
Othar Inducars of Ectopic Protain Synthasis 
Whan Ghosh at al. (1977) raportad tha induction of hCO synthaais in 
KaLa calls by butyrata, thay suggastad that tha induction nay ba ralatad 
to tha inhibition of call growth and DMA synthasis. For axoopla, both 
arythrodiffarantiation (Ladar at al., 1975) and myoblast diffarantiation 
(Koltaar at al., 1972) ara pracadad by a cassation of call growth. In 
fact, savaral groups bsva obsarvad that cartain comwunds which inhibit 
DMA synthasis also induca hC6, PAP, and othar protains. Thasa compounds 
ineluda bydroxyuraa (Ghosh and Cox, 1977; Ghosh at al., 1977; Chou and 
Robinson, 1977b), thymidina (Park, 1981). fluorodaoxyuridina (Park, 
1981), bromodaoxynridina (Koyama and One, 1970; Buloar at al., 1976; 
Chou and Robinson, 1977a), iododaoxyuridina (Gos, 1974), eytosina 
arabinosida (Hoaccma at al., 1970; Chou and Robinson, 1977b; Ghosh at 
al,, 1977; Oautsch at al., 1977), aphidicolin (Cox and Park, 1982), and 
phosphonoformic acid (Cox and Park, 1982). 
Most of thase compounds hava a proposed nachanism of ONA synthesis 
inhibition, iiydroxyurea (Lewis and Uri^ t, 1974; Yeh and Tessman, 1978) 
and thymidine (Richard, 1978; Morris and Fischer. 1963) inhibit 
ribonucleotide reductase. Fluorodeoxyuridine inhibits thymidylate 
synthetase (Friedkin, 1973; Oanenberg. 1977). Bromodeoxyuridine 
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(Bischoff and Koltzar, 1970; Stallwagen and Tonkins, 1971; DJordjavic 
and Ssybalaki, 1960) and iododaoxyuridina (Go: and Walkar, 1976) act as 
daoxynuclaosida analogs and ara incorporated into tha DMA. Cytosina 
arabinosida may inhibit DMA synthesis by aithar incorporation into tha 
DNA (Kufa at al., 1980; Chu and Fischar, 1965; Silagi, 1965) or 
inhibition of DNA polymaraaa (Graham and Vhitmora, 1970). Aphidicolin 
(Ikagaai at al., 1978; Ohashi at al., 1978; Oguro at al., 1979) and 
phosphonoforalc acid (Ralgstrand at al., 1978; Rano at al., 1978; Chang 
at al., 1981) inhibit DNA polymaraaa a activity. In tha casa of 
aphidicolin-rasistant mutants, savaral studies suggest that a major site 
of action may involve daoxynucleosida oMtabolism rather than DNA 
polymerase a. Cells resistant to aphidicolin have expanded 
daoxynucleosida triphosphate pools, particularly deoxyadenoslne, and an 
altered ribonucleotide reductase, but not a less sensitive DNA 
polymerase a (Sabourtn at al., 1981; Ayusawa at al., 1981). 
Other compounds such as actinomycin 0. bleomycin, ethidium bromide, 
macromomycin, and cesalin. which inhibit DNA synthesis as a result of 
intercalation or DNA strand scission, do not induce either hCC-a or PAP 
in HeLa cells (Park, 1981). In choriocarcinoma cells. Chou and Robinson 
(1977b) observe that three compounds which alter DNA structure, cytosine 
arabinoside, mitomycin C and phleomycin. also induce alkaline 
phosphatase activity. It appears, in general, that those compounds 
which alter either deoxynucleoside metabolism or are theoHielves 
deoxynucleoside analogs also induce hCG-a and PAP (Park. 1981). The 
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mchânisa of induction of oust of thus compound* is unknown. This 
study «xâainos th# expression of hCO-a and PAP in HeLa calls to saa if 
thay ara eo-ordinataly ragulatad and to battar undarstand tha action of 
various inducers and effectors By studying factors which alter the 
expression of these genes, important regulatory elements may be 
elucidated. 
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MATERIALS AND METHODS 
Method» 
Cell culture 
2 Various KeLa cell line# were grown in 75 cm culture T-fl@*k# in 
minimum essential medium (MEM) supplemented (MEMO) with 0.06% L-
glutamine, 100 units/ml penicillin and 100 ug/ml streptomycin. 0.22% 
sodium bicarbonate, and 6-7.5% serum (fetal calf or calf). These lines 
included HeLa 2, 2.1, and 2.2 from the American Type Culture Collection 
and KeLa S'3 from Norm Cooper and Or. Bernard Moss at the National 
Institutes of Health (NIH). Cells were fed with fresh MEMC every 2-3 
days. When cells reached confluency, they were passaged by adding 5 ml 
of 0.01% trypsin in Hank's balanced salt solution with 0.02% EDTA and 
without CaClg and MgSO^ . Ten ml of MEMC was then added to the 
trypsinized cell suspension and 5 ml of this diluted cell suspension was 
added to 10 ml of MEMC in another 75 cm^  flask. 
Induction protocol 
2 Most induction experiments were performed in 25 cm culture T-
flasks. One ml of a diluted trypsinized cell suspension from a 
2 2 
confluent 75 cm culture was added to 4 ml of MEMC per 25 cm flask 
5 2 (about 6 % 10 cells/ 25 cm flask). Cells were grown to near 
confluency. The experiment was then started by feeding the cultures 
with 5 ml of fresh MEMC and adding the appropriate inducer and/or other 
effectors. After 3 days growth under the experimental conditions, the 
cells and media were harvested. 
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Harvesting of cells 
Cells were harvested by scraping the cells into the growth medium 
of that flask with a rubber policeman. Cells (attached and detached) 
and cell debris were removed from the medium by ceqtrifugation at 2,000 
rpm (980 x g) % 10 min in an International centrifuge. The cell free 
supernatant was transferred to a test tube and frozen for assay of hCC's 
at a later time. The cell pellet was washed twice with 1 ml of 50 mM 
TriS'HCl (pK 7.4), 0.9% (w/v) NaCl (Tris-saline). The cell pellet was 
then resuspended in 0.5 ml of Tris-saline and frozen. 
Preparation of cell extracts 
The frozen cell suspension was thawed, and deoxycholate was added 
to 0.5% (w/v). The calls were disrupted by sonicaeion with a Branson 
Bonifier (nicrotip. output setting 6, 50% duty cycle, 2 min). Aliquots 
of this crude sonicate were then assayed for alkaline phosphatase 
activity and protein content. 
Alkaline phosphatase assay 
Alkaline phosphatase (EC 3.1.3.1) activity was assayed according to 
the procedure described by Edlow et al. (1975). The assay mixture 
contained cell sonicate (100 ul or less). 0.75 M 
Z-amino-Z-methyl-l-propanol (pH 10.7). and 8 mM p-nitrophenyl phosphate 
in a total volume of I ml. The samples were incubated in a 37° C water 
bath until the color in the extract tubes developed significantly above 
the blank. Assays containing less than 2 mU of activity were linear for 
up CO 30 min. The reaction was terminated by the addition of 0.5 ml of 
0.2 N MaOH and removal of the sample from the water bach. The 
absorbance of the samples was measured at X"400 nm in a Gilford 
spectrophotometer. The amount of enzyme activity in the sonicates was 
determined from the equation: (A^ QQ/c)(1.5ml/s.v.)(l/18.3) • unies of 
alkaline phosphacase activity/ml, where t is the time of incubation at 
37° C. is the absorbance at 400 nm, 1.5 ml is the total assay 
volume, s.v. is the sample volume, and 18.3 is the mM exeinccion 
coefficient for p-nicrophenol. One unie of activity was defined as the 
amount of enzyme which would catalyze the hydrolysis of 1 umole of p-
nicrophenylphosphace in 1 minute at pH 10.7 and 37° C. 
Protein assay 
The amount of cellular protein in each sample was determined from 
cnide cell sonicates according to the procedure of Lowry et al. (1951). 
Bovine serum albumin (BSA) was used as the protein standard. 
Radioiwawmoassav for hCG«o 
The alpha subunic of human chorionic gonadotropin (bCG-s) was 
assayed via a competition reaction with radiolabeled hCG-e for antisera 
raised to urinary bCG«a (anti«o). The hCG-e used for tka standard curve 
and radiolabeling was prepared by Canfield and supplied by the NIK 
(CR-123). Antisera was prepared against hCG-o purified by Cox (1981a). 
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The alpha subunic was radiolabeled with I using a 
laccoperoxidase method (Roth, 1975). The reaction mix consisted of 15 
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Ul of 0.05 M sodium phosphate (pH 7.4), 5 xg of hCG-a, 10 yl of 0.6 M 
sodium acetate (pH 5.6), 2 pi of bovine lactoperoxidase at 2.7 ng/ml in 
0.1 M sodium acetate (pH 5.6) (\|2^ 2^80* 2 ul of 30* HgOg 
diluted 1/15,000 immediately before use (67 ul/l liter K^ O). The 
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reaction was started by the addition of 0.5 mCi of Na[ I) (sp. ace. • 
17 Cl/mg). After 60-90 seconds, the reaction was stopped by the 
addition of 100 ul of a solution consisting of 16% sucrose, 1% KI, and 
125 0.02% sodium aside. lodinated hCG«a was separated from unbound ! by 
chromatography over a 0-100 column in 50 mM potasium phosphate (pH 7.4), 
0.1* BSA, 0.02* SaNj buffer. One ml fractions were collected at a rate 
of about 0.2 ml/min. The column fractions were counted in a manual 
solid scintillation gamma counter and those fractions corresponding to 
the radiolabeled monomer of hCC-a with at least 10^  cpm/fraction were 
stored at 4^  C. Radiolabelling by this procedure routinely resulted in 
the incorporation of 40-60% of the I into hCG-a with a specific 
activity of about 50 itCi/ug. 
Antisera was raised to hCC-o in rabbits as outlined by Park (1981). 
The assay ctmsisted of a standard curve with unlabeled h(^ -a (1 ng to 
100 ng) and Rwdium samples (50 ul to I ml). The volume was brought to a 
total of I ml with 50 mM potassium phosphate buffer (pH 7.4) containing 
0.1% BSA and 0.02% SaH^ . To each tube was added 50,000 cpm of 
radiolabeled hCG-a and 10 ul of anti-a sera (diluted 1:50). The anti-o 
sera was diluted such that 10 ul/l ml would precipitate 30% of the hCG-e 
present. This mixture was incubated for a minimum of 15 hours at room 
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temperature. Following this initial incubation, 30 wl of goat anti-
rabbit IgG was added to precipitate the anti-a complexes. This second 
incubation went for 1 hour at 37^ C and then overnight at room 
temperature. Alternatively, 0.2 ml of 10* Staphlococcus aureus solution 
(prepared as described below) in SO mH potassium phosphate (pH 7.4), 
0.9* NaCl (PBS) was added and incubated for at least 30 minutes at room 
temperature. The precipitate was pelleted by centrifugation at 2,000 
rpm for 10 min in a Beckman TJ-6 tabletop centrifuge. The supernatant 
was transferred to another tube and the pellet was washed with either 1 
ml of PBS containing 0 1* BriJ for the goat anti-rabbit pellets or I ml 
of PBS for the S. aureus pellets. The wash supernatant was combined 
with the first supernatant. The amount of radioactivity in both the 
supernatant and pellet was measured using either a manual solid 
scintillation gamma counter or an automatic gamma counter. The assay 
125 
results were expressed as the percent of I cpo in the pellet (i.e., 
cpm pellet/ (*^ *I cpm pellet + epm super)) x 100). The 
amount of the hCG-o present in the experimental samples was calculated 
by comparing the corresponding percent cpm in the pellet with the 
percent cpm in the pellets of the standard curve. 
Separation of Staphlococcus aureus-bound protein A 
The Cowen I strain of Staphlococcus aureus (ATCC 12598) was 
obtained from Dr. Peter Patee in the Department of Microbiology at Iowa 
State University. Protocol for preparing S. aureus was obtained fzom 
ED. Rosenblum, Department of Microbiology, Health Science Center. 
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University of Texas, Dallas, Texas. One hundred nl of 3% trypcicase soy 
broth (TSB) in a 250 nl Erlenmeyer flask was inoculated from a slant of 
Cowan I stock culture and grown overnight at 37^ C with shaking. 
Multiples of one liter of TSB in 2 liter Erlenmeyer flasks were 
inoculated with 10 ml of the overnight culture. These one liter 
cultures were shaken at 37^  overnight but not longer than 15 hours. The 
cells were harvested by centrifugation at 10,000 x g for 10 nin. The 
cells from all the flasks were combined into a pre-weighed centrifuge 
bottle and washed twice with PBS. The cell pellet was resuspended (w/v) 
to 10% in PBS. Concentrated formaldehyde was added to 1.5% (4.05 ml of 
37T« formaldehyde/100 ml) and the mixture was stirred for 90 minutes at 
room temperature. Following pelleting of the cells, they were 
resuspended to 10% (w/v) in PBS and heated at 80°C for exactly 4 minutes 
in 100 ml aliquots in a 1 liter flask. The suspension was immediately 
cooled on ice. This heat treatment was repeated until the whole 
suspension was processed. Cells were pelleted by centrifugation at 
10,000 X g for 10 minutes and washed once with PBS containing 0.02* 
NaNj. Cells were transferred to a pre-weighed bottle, pelleted, and 
resuspended to 10% (w/v) in PBS containing NaNg. This 10% solution of 
S. aureus was used to pellet the antigen-antibody complexes of the hCS-o 
RIA. 
Measurement of DMA. RNA. and protein synthesis 
HeLa cells were grown to near confluency in 24 well cluster plates. 
Cultures were fed with I ml of fresh MEMO and the experimental effectors 
were added. At the appropriate times, 1 wCi of the appropriate 
radiolabeled precursor was added to each well and incubated for 4 hours 
at 37^ C, S* COg/SS* air. The radiolabeled precursors used for these 
3 3 
experiments were ( K) deoxyadenosine or { H) thymidine for measuring QNA 
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synthesis, ( H] uridine for measuring RNA synthesis, or C-labeled 
aminoacid mix for measuring protein synthesis. Cells were harvested by 
transferring the medium to 12 x 75 mm test tubes and adding 200 ul of 
trypsin to each well. When the cells detached, they were added to their 
corresponding medium. The cells were pelleted and the media supernatant 
was removed and frozen for a later hCC'o assay. The colls were washed 
twice with 1 nl of Tris-saline, and the final cell pellet was 
resuspended in 1 nl of the same buffer. One ml of ice cold 10% 
trichloroacetic acid (TCA) was added to 0.5 nl of the cell suspension 
and left on ice for 30 min. The other 0.5 nl of the cell suspension was 
frozen for a protein determination. The TCA precipitated material was 
collected on either Hillipore 0.45 vm pore nitrocellulose filters or 
Whatman GF-C glass fiber filters and washed with ice cold 5% TCA. The 
filters were dried, placed in a toluene fluor (19 g 2.5*diphenyloxazole 
(PPO), 0.95 g l,4-bis-(5-phenyloxazolyl)-benzene fPOPOP)/ 3.8 liters of 
Toluene) and counted in a Becknan scintillation counter. 
Deoxvnucleoside triphosphate (dNTP) assay 
The levels of dNTP in a sample were determined using E. coli DMA 
polymerase 1. a template primer, and radiolabeled dNTP (Walters et al., 
1973; Skoog, 1970; Lindberg and Skoog, 1970). DMA polymerase I 
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catalyzed the incorporation of deoxynucleotides onto a template primer. 
The extent of the reaction could be controlled by limiting the 
availability of a particular nucleotide. Utilizing the radiolabeled 
nucleotide precursor complementary to the limiting nucleotide, the 
reaction was monitored via the incorporation of the radiolabeled 
nucleotide into TCA insoluble material. That is. since equimolar 
amounts of complementary nucleotides are incorporated, the level of 
incorporation of the radiolabeled nucleotide into TCA insoluble material 
reflected the level of its unlabeled complementary nucleotide present in 
the sample. 
The assay consisted of establishing a standard curve with known 
amounts of unlabeled dKTP (0.5 to 10 pmoles from 0.5 wM stocks) to 
compare with samples with unknown levels of the nucleotide. The volume 
of the samples and standards was brought up to 40 ul with 10 mM Tris-HCl 
(pH 7,4). With the samples on ice, 160 ul of a prenix consisting of 100 
ul of SO mM Tris (pH 8.0) for dATP/dTTP assays or 100 ul of 80 oM Tris 
(pH 8,6) for dCTP/dGTP assays, 10 ul of 100 mM MgClg, 20 ul of 5 uM 
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coBplementary { Hl'dKTP, 3,4 ul of 500 wg/«l poly (dA dT) template 
primer for dATP/dTTP assays or 3,4 ul of 500 wg/ml poly (dl dC) template 
primer for dCTP/dCTP assays, 20 ul of 25 units/ml DMA polymerase I and 
6,6 ul of deionized distilled water was added to each sample. The 
samples were placed in a 37°C water bath for one half hour. The 
reaction was stopped by chilling the saaq>les on ice and adding O.l ml of 
a mix containing 6,4 waoles sodium pyrophosphate, 4 umoles EIXTA, and 1.5 
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mg/ml BSA. MacromoUcular material was precipitated by adding 1 ml of 
ice cold 10% TCA and keeping the samples on ice for 15 min. The 
precipitates were collected on Whatman GF/C glass fiber filters which 
had been presoaked with 0.2 ml of 0.1 M sodium pyrophosphate. The 
filters were washed with 10 ml of 5* TCA, dried, placed in Toluene 
scintillation cocktail fluor, and counted n^ a Beckman scintillation 
counter. 
E. coH DMA polymerase I was diluted from a 4,000 U/ml stock with 
100 1^  Tris-KCl CpH 8.3), 1 mM 1,4-dithiothreitol (OÎT). and 0.5 mg/ml 
BSA to 25 U/ml. The template primers (poly (dA dT) and poly (dl dC)) 
were dissolved in 10 mM Tris-HCI (pK 7.4), 0.1 H N'aCl. Oeoxynucleoside 
triphosphates were diluted with 10 mM Tris-HCI (pH 7.4) to 0.5 uM. The 
radiolabeled nucleotides were diluted to a 5 uM concentration with 10 oM 
Tris-HCI (pH 7.4) from stocks of I mCi/ml (^ H) dATP (17 Ci/mmole), (^ H) 
dTTP (44 Ci/nmole), (^ H] dCTP (30 Ci/nmole), and f'^ HI dtTTP (16 
Ci/mmole). The template primers and unlabeled deoxynucleoside 
triphosphates were supplied by P-L Biochemical Company and the 
radiolabeled precursors were supplied by Amershan. Bethesda Research 
Laboratories (BRL) supplied the E. coH DMA polymerase I. 
Determination of intracellular cAHP 
In order to accurately determine the intracellular levels of cAMP, 
it is crucial that acid soluble extracts are prepared as quickly as 
possible. Therefore, an aspirator was used to remove the medium and 2 
ml of ice cold 5* TCA was added immediately to the attached cells. The 
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cells were scraped into Che TCA with a rubber policeman and transferred 
to a 12 X 75 mm test tube. The plate was rinsed with 1 ml of ice cold 
5% TCA and added to the original extract. The TCA insoluble material 
was pelleted by centrifugation at 9,800 x g for 10 min. The supernatant 
was transferred to a 10 ml extraction tube and extracted 4 times with 
1.5 volumes of ether which had been acidified by extraction with two 
equal volumes of 1 N KCl. The ether was discarded, a stream of X, was 
gently bubbled through the extract to remove residual ether, and the 
sample was stored at -20®C. The extract was later thawed, lyophiiized, 
and refrosen (-ZO^ C). This lyophilized material was thawed and 
resuspended in 0.5 ml of 10 aM Tris-HCl (pH 7.4),  ^ISO ul aliquot was 
removed, brought to 90 mM Tris with 1 M Tris-KCl (pH 7.5), and assayed 
3 for cAHP using a ( H) cAMP assay kit and protocol supplied by Diagnostic 
Products Corporation. The TCA insoluble material was solublized in 0.5 
ml of 0.5 N NaOH and assyed for protein. 
Partial purification of HeLa-o 
Medium was collected from Kela S*3 cells grown in spinner culture 
and concentrated ten fold in an Amicon concentrator/dialyzer. Technical 
grade dioxane was added to 50% (v/v) in 4 portions (15 min intervals) 
and mixed for one hour at room temperature. Dioxane insoluble material 
was removed by centrifugation. Following dialysis against water, the 
dioxane soluble protein was precipitated by adding solid ammonium 
sulfate to 90% (w/v). The ammonium sulfate precipitate was collected by 
centrifugation and resuspended in buffer appropriate for the column 
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chromatography of the next purification scap (see Column chromatography 
section, below). 
Desialvlation of hCO-a 
Partially purified hCG-a was desialylated according to a modified 
procedure of Oufau et al. (1972). The sample was dialyzed against water 
and 1 M sulfuric acid was added to 60 mM. The sample was heatad at 80°C 
for 90 min. After the sample had cooled, it was neutralized with I M 
SaOH and then dialyzed against PBS. 
Column chrcmatosraphv 
DEAE-Cellulose: The ammonium sulfate precipitate was resuspended 
in SO to 100 ml of water and dialyaed against the equilibration buffer, 
10 mM potassium phosphate (pH 8.0) with 0.02* (w/v) NaN^ . The sample 
was applied to the column (I liter) in a volume of 50 to 100 ml. 
Unbound material was eluted with one liter of equilibration buffer, and 
bound material was eluted with a 2 liter gradient of NaCl (0 to 0.3M) in 
equilibration buffer. Ten ml fractions were collected with the initial 
20 to 25 fractions being collected at a slower flow rate to facilitate 
binding of protein to the column. For all column chromatography, bulk 
protein was determined from the Aggq each fraction and Hela-a was 
detected by RIA. 
Sephadex G-75 Superfine: The G-75 column was equilibrated in 0.1 M 
ammonium bicarbonate, 0.02% (w/v) NaN^ . The ammonium sulfate pellet was 
resuspended in equilibration buffer. For caparison with placental 
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hCG-@, 200,000 cpm of iodlnaced placental alpha was co-chromatographed 
with the KeLa sample. The protein was eluted with 500 ml of 
equilibration buffer and collected in 2.5 ml fractions. Elution of the 
125 
I-labeled hCG-a was monitored by counting each fraction in a solid 
scintillation counter. 
Lectin Chromatography: Partially purified HeLa-a was 
chromatographed on Concanavalin A-Sepharose or Ricin-agarose as 
described by Cox (1981c). Both columns were washed with high salt 
buffer (0.1 M sodium acetate (pH 6 0); 1 M NaCl; 1 ibM MgCl^ ; 1 mM CaCl^ ; 
1 mM MnClg: 0,02" (w/v) NaN^ }. and then equilibrated with PBS * 0.02* 
(w/v) aside at room temperature. The HeLa sample was applied in I ml 
aliquots at 5-15 min inteivals until the entire sample was absorbed on 
the column. The sample was left undisturbed on the colunm for 30 min. 
Unbound material was then eluted with PBS ^  0.02* (w/v) aside in 1 ml 
fractions. Matrix bound material was eluted from Con A with 0.2 M 0* 
alpha methylglucoside in PBS and from the ricin column with 0.2 M D-
galactose in PBS. 
Isolation of material for mBNA analysis 
Cytoplasmic soluble material was isolated from KeLa cells as 
described by White and Bancroft (1982). Cells grown in 25 co^  flasks 
were scraped into 5 ml of PBS containing 0.02% (w/v) sodium aside, 
washed once with PBS, and then pelleted in a 1.3 ml Eppendorf tube. The 
cells were resuspended in 45 ul of ice cold 10 mM Tris-HCl (pH 7). I arfl 
ESTA, and lysed by adding two 5 ul aliquots of 5*. (v/v) Nonidet P-40 
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detergent S min apart with mixing on ice. Nuclei were pelleted by 
centrifugation in a Fisher microfuge for 2.5 min. Fifty microliters of 
the supernatant were transferred to a 1.5 ml Eppendorf tube containing 30 
111 of 20X SSC (IX SS00.15 M NaCl, 0.015 M sodium citrate (pH 7) and 20 
of 37* (v/v) formaldehyde. The sample was heated at 60^ *0 for 15 min 
and then stored at -70°C. The nuclear pellets were stored frozen, then 
resuspended in 0.5 ml of Tris-saline and prepared for protein and 
alkaline phosphatase assays. 
Cytoplasmic samples were thawed and heated at 60°C for at least 15 
min. then serially diluted in a 96"well microtiter dish from 1:50 to 1:5 
with 15% SSC to a final volume of 150 wl. Twenty microliters of each 
sample were also diluted with 15X SSC to a final volume of ISO yl anJ 
treated with RNAse (10 wg/ml) for at least 1 hour at 37^ C. One hundred 
microliters of each dilution were applied with suction to a sheet of 
nitrocellulose (BA 85 (0.45 wm) presoaked in 20X SSC) supported on a no. 
470 paper utilizing a 96 hole manifold filtration apparatus. The 
filtration apparatus, nitrocellulose, and support paper were supplied by 
Schleicher and Schuell. The samples were baked onto the nitrocellulose 
by drying at 60^ C in a vacuum oven for 90 min. 
Growth and isolation of g-cDNA plasmid 
ONA complementary to hCG-a mRKA was cloned into the plasmid pBR322 
by Fiddes and Goodman (1979) and generously donated by Or. J. Fiddes. 
Ten ml of L-brotb (1% Bactocryptone, 0.5%, Baccoyeasc extract. 1% NaCl, 
pH 7.5). was inoculated with E. coli strain RBI (Amp^ , Tet^ ) carrying 
the hCG-a plasmid and placed in a 37°C shaker. TWo hours after 
inoculation, freshly filtered ampicillin was added to a concentration of 
20 wg/ffll. Following an overnight growth the culture was diluted 1:50 
into 1 liter of L broth and grown with vigorous airation at 37^ C. 
Growth of the culture was monitored by removal of 1 ml and measuring the 
absorbance (light scattering) of the aliquot at 600 nm. When the 
culture reached an O.D.ggq of 1.0 (determined by extrapolation of the 1 
ml readings), chloramphenicol was added to 184 tig/ml. Cells were grown 
overnight with vigorous shaking. The cells were harvested by 
centrifugation at 8,000 rpm for 10 min in a JA 10 rotor (11,320 % g). 
The cells were resuspended in Tris-sucrose (50 mM Tris-HCl (pH 8.0), 20* 
(w/v) sucrose) to a final volume of 25 ml. 
Three ml of freshly prepared lysosyme solution (10 mg/ml in 0.25 M 
Tris-HCl, pH 8.0) were added and gently swirled continuously for 5 min 
on ice. Three ml of 0.25 H ESTA (pH 8.0) were added. With gentle 
swirling, 30 ml of 0.2% (w/v) Triton X-lOO , 50 mM Tris-KCl (pH 8.0) and 
25 mM EDTA (pH 8.0) were gradually added to lys* the cells. The 
solution was placed at room temperature for 15 min and stirred 
frequently. The cellular debris was pelleted by centrifugation at 
15,000 rpm for 30 min at 5**C in a JA 20 rotor (27,200 x g). The cleared 
lysate was carefully decanted to a precooled graduated cylinder. 
Nine grams of CsCl were added to 8.7 ml of the cleared lysate. The 
CsCl was dissolved by adding it very slowly and gently rocking the 
solution from end to end. The solution was refrigerated overnight 
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followed by the gentle rocking to dissolve any undissolved CsCl. The 
refractive index of the solution was adjusted to 1.394 by the addition 
of either CsCl or the lysis solution, and then 0.S ml of 10 mg/ml 
ethidium bromide was added. The sample was centrifuged at 36,000 rpm at 
15°C in a Beckman Ti 50 fixed angle rotor until two bands of ONA were 
visible upon illumination with a UV light source (at least 40 hours). 
The lower band, consisting of covalently closed circular plasmid DNA, 
and was collected by first discarding the material above the band. The 
plasmid DNA was then removed using a plastic Pasteur pipet in less than 
0.5 ml aliquot* starting at the bottom of the band. Collection was done 
in a dark room to avoid direct light which would damage the intercalated 
DNA. 
Ethidium broside was removed from the plasmid by extraction with 2 
volumes of isopropanol equilibrated with 20% SSC. Extraction was 
complete when the DNA sample fluoresced blue instead of pink upon 
exposure to long wavelength UV light. Residual ethidium bromide was 
removed by dialysis against 2 liters of TE buffer (10 mM TriS'HCl, pH 
8.0; I mM ESTA). The concentration (Ag^ q) and the purity (^ 26(/^ 280^  
was determined before freezing the sample. 
Nick translation 
Nick translation of the o-cONA plasmid followed a modified 
procedure of Sigby et al. (1977) supplied by Dr. Richard Haurer at the 
University of Iowa. The DNAse solution was activated the day of use by 
diluting 20 ul of DNAse (I mg/ml in 0.01 H HCl) with ISO ul of 
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activating buffer (0.01 H Tris-KCl (pH 7.5); S mM MgClji and 1 mg/ml 
BSA) and setting the solution on ice for 2 hr. Immediately before use, 
5 wl of the activated ONAse was diluted with 2 ml of the activating 
buffer. The reaction was mixed on ice and consisted of the sequential 
addition of 2 wl of 10% buffer (0.5 M Tris-KCl (pH 7.5); 0.05 M MgCl,), 
2 wl of 10% dNTP (0.2 mM dATP, dGTP, dTTP), 0.1-0.5 wg of DMA in 2 wl, 
100 pmoles of [a-^ P^] dCTP (> 600 Ci/mole) in 14 wl» and 2 wl of DXAse. 
The DNAse reaction was incubated for 5 min at room temp. The sample was 
chilled for 15 min on ice. Ten units of DMA polymerase I (supplied by 
BRL) was added and incubated at 15°C for 2-5 hr. At the end of the 
reaction, 10 wl of 0.1 M COTA and 40 wl of 0.4 M KaOH were added and 
then heated at 68°C for 5 min. The nick translated probe was separated 
32 ___ from unincorporated ( P] dCTP by chromatography over a 10 ml Sephadex 
G-50 column equilibrated with the elution buffer (TE. pH 8.0). 
32 
Fractions of 0.5 ml were collected and the elution of P-labeled 
material was monitored by Cerenkov counting. Those fractions 
corresponding to the nick translated probe were stored at 4**C. Specific 
g 
activities of > 1 x 10 cpm/wg of DNA were routinely obtained with the 5 
hr DNA polymerase I incubation. 
Filter hybridization 
The baked nitrocellulose filter was placed into a heat sealabU 
plastic bag (Seal-a-Meal, Seaxs-Soebuck Co.). The filter was 
prehybridized at 42®C for 8 hours in hybridization buffer (50% (v/v) 
deionized formamide; 5X SSC; 50 mM sodium phosphate (pH 6.5); 250 wg/ml 
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salmon sperm DMA; IX Denhardt's solution (SOX * !!• (w/v) Ficoll; 1% 
(w/v) polyvinylpyrrolidone; 1% (w/v) BSA (Pentax Fraction V) (Maniatis 
et al., 1982)). The prehybridization mixture was renwved and replaced 
2 32 
with hybridization solution (SO ul/cm ) consisting of P-labeled a-pBR 
2 probe (IS,000-50,000 cpm/cn ) in 4 parts hybridization buffer and 1 part 
SO* (w/v) dextran sulfate at 42*C for 24 hours. The salmon sperm DMA 
and the a-pBR probe were boiled for S minutes and added immediately to 
the hybridization solution. To minimize the formation of air bubbles on 
the nitrocellulose, both prehybridization and hybridization solutions 
were warmed to 42^ 0 before addition to the filter and the air In the bag 
was removed before it was sealed. The filter was removed and washed 
four times (5 min each) in 2X SSC and 0 1* (w/v) SOS at room temp. The 
filter was then washed two times (IS min each) in 0.1 X SSC and 0 1% 
(w/v) SDS at SO^ C. The filter was dried between 2 pieces of 3 MM paper, 
taped with the RNA side up to aother piece of 3 MM paper, covered with 
Saran Wrap, and placed in a film cassette against a sheet of X-ray film 
(Kodak XAR-S) and intensifying screen. The film was exposed for 12 
hours at -TO^ C. 
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RESULTS 
Comparison of hCG-a and PAP production in H«La cell lines 
HeLa cell lines produced hCG-a and PAP at levels characteristic of 
that cell line (Table I). Relative to one another. CCL 2.1 was the 
lowest hCG-a producing cell line (139 ng/mg protein/72 hr) while CCL 2 
was the highest producer (486 ng/mg protein/72 hr). CCL 2.2 and S-3 
produced intermediate levels of hCG*a (352 and 318 ng/mg protein/72 hr, 
respectively). With regard to PAP. HeLa S-3 had the highest activity 
(7.5 mU/mg protein) and CCL 2 had the lowest activity (l.é mU/mg 
protein). HeLa 2.1 and 2.2 were intermediate in PAP activity (3.4 and 
2.7 mU/ng protein, respectively). Thus, a production and PAP activity 
were not correlated. That is. the cell line with the highest 
constitutive level of s production had the lowest level of PAP activity 
(CCL 2). The lowest a producer had an intermediate level of PAP (CCL 
2 1). Also, those cell lines exhibiting the greatest difference in PAP 
activity (2 and S-3) had similar rates of hCG-a production. This 
observation that high hCG-o synthesis did not also correspond with high 
PAP activity in the same cell line suggests that these two proteins are 
not regulated in a co-ordinate fashion. 
In these experiments comparing a and PAP expression among HeLa cell 
lines, as well as the protein induction experiments presented in the 
following sections, the level of a production and PAP activity varied 
from experiment to experiment. Although the reason for this variability 
3ft 
Table I 
PAP activity and hCC-a production in varioua HaLa call linaa 
HaU hCG-O PAP 
call lina ng/mg prot mU/mg prot 
ct. .  T 6*6 2 112 (8) t .6 « 1.7 (d> 
ccr,  2 1 £ 149 (9> 3.4 : 2.0 I?) 
C(l 2.2 352 S 28i (»> 2.7 s 1.5 (8> 
KIM S-3 318 t  229 (10) 7.5 £ 6 . t  (8> 
Various HaLa call linaa tiara grown for thraa daya in MEMO, 
harvaaead, and aaaayad for hCC«ef production and PAP activity aa 
daacribad in Matariala and Kathoda. Cartifiad call linaa (CCL) 
wara provided by tba Aoarican Typa Culture Collection while NIB 
S-3 W6é a gift from Nom Cooper a, Thtt number cr replicate* 
for 91 Uacermlnatlon is given iu parenthesla. 
is unclear, culture conditions, such as variability among batches of 
serum and cell density (see Pig 8) may significantly effect the 
expression of these genes. Thus, in cell line studies, results were 
compared between cultures grown simultaneously. While the magnitude of 
an effect on a and PAP expression may vary from one experiment to the 
next, the observations are valid as indicated by the variance 
illustrated in Table I and Table IV. A t test analysis between the 
lowest and highest producers of both PAP (CCL 2 vs. SIH 5-3) and hCC-a 
(CCL 2 vs. CCL 2.1) gave values of t » 2.46. p < 0.014 and t * 2.79, p £ 
0.005, respectively. 
These cell lines also varied in their response to butyrate (Fig 1). 
For a given cell line, a strong stimulation of hCC-a production did not 
necessarily correlate with a strong induction of PAP. For example, KeLa 
S*3 showed the strongest induction of hCG«a but the lowest PAP 
induction. Kela 2 had the lowest hCC-o induction but the highest PAP 
induction. Furthermore, the degree of induction did not correspond with 
the uninduced levels; that is, in this experiment, KeLa 2.1 and 2.2 
differed by about S5 fold in basal levels of hCG-a but were similar in 
their res^ nse to butyrate. HeLa 2 and S-3, which bad comparable 
control levels of hCG-o, exhibited about an 8-fold difference in 
response to butyrate. With regard to PAP activity, HeLa 2 had the 
lowest constitutive level but the greatest fold induction by butyrate. 
HeLa S-3 bad the highest constitutive level of PAP but the weakest 
response to butyrate. These data suggest that butyrate may be 
Figure I. Oo«*-r«fFOfW« eurvca for eh« bueyraco induceion oi hCC-dand 
PAP is BaLa call linaa. inaw calla (CCL 2, 2.1, 2.2, and NIB 
S-3) wra grown in MEMC (eonerol) or in madium containing 
bucyrata from 1 co 10 aM for ehraa daya. Tha calla «ara 
barvaatad and aaaayad for (A) PAP aceiviey and (B) bCG-a aa 
daaeribad in Macariala and Macboda. Control valuaa ara givan 
in Tabla I. Sysbola: 2 W. 2.1 (O). 2.2 (A), S-3 <•). 
Control values are O.ll. 0.56, 0.63. and 0.88 mU/mg protein of 
PAP and 50. 4, 341, and 71 ngct/ng protein for 2, 2.1, 2.2. and 
S-3, reapeet4v»ly.{ 
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metabolized differently from one cell line to another, or that butyrate 
is metabolized similarly but that there are cell line differences in the 
regulation of hCO-a and PAP expression in response to butyrate. These 
data are also supportive of the discordant regulation of hCG-a and PAP. 
Partial purification of HeLa hCG-a 
The difference in alpha production between the various KeLa cell 
lines may be reflected by physicochemical properties of the protein. In 
order to characterize HeLa-o from a low and high producer (see next 
section), a scheme to partially purify alpha from the medium was 
developed using spinner cultures of S-3 cells as described in Materials 
and Method*. Fig 2 shows the chromatography of this material over a 
column of DEAE-cellulose. The majority of hCG-o did not bind to the 
column while the majority of protein did bind. The unbound material 
(fractions 70 to 160) was pooled and the protein was precipitated by 
adding (NH^ )2S0^  to 90% (w/v). The pellet was collected by 
centrifugation at 25.960 % g for 30 min and then resuspended in 5 ml of 
0.1 H NH^ HCOj. This material was chromacographed over a column of 
Sephadex 6-75 superfine as described in Materials and Methods except 
radiolabeled hCC'O was not included. The chromatography profile shows 
that He&a-* elueed in a volume of buffer greater than that of the 
majority of protein (Fig 3). Calculations in Table U indicate that a 
purification of about 5.000 fold was achieved by this protocol. 
i Ha 
## 111 m Ml m at »• 
fraction nuniiiar 
Figure 2. Chromatography of WeLa-a on DEAS-cellulose. [Partially purified UeU-O was 
chromatographed over a column of DEAR-cellulo@e aa described in Materials aiw* Methods.J 
100 .40 
•O 
#0 
m 
40 
à» 
to 
o 40 #0 120 
Iractton number 
Figure 3. Cliromitograpby of HeLa>o on Sephedex C 75 Superfine. (Partially purified HeLa-a was 
chromatographed over a column of Sephadex C 75 Superfine aa described in Materials and 
Methods.1 
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Table II 
Purification of ReLa-a * 
Sample 
Bela-@ 
n 
Protein 
*280 *280 
Fold 
purification 
Amleon eoneentrate 36,000 1.5 X 10® 0.02 1 
(»B^ )2S0^  3,300 1.6 X 10^  2.03 102 
Fooled G-75 598 6 99.67 4984 
"gaLm-O waa partially purified aa deaerlbed in the text and In 
Materlalm and Mathoda. 
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Comparison of hCG-a from H«La S-3 and 2.1 
Lisblich at al. (1976) obsarvad that hCG-a sacratad by HaLa 2.2 
calls had a lowar alution voluma on gal chromatography than hCG-a 
suggasttng that tha ectopic protain had a highar molecular weight than 
the normal subunit. Differences in the carbohydrate moiety of the two 
proteins may account for this chromatographic behavior (Cox 1981b). To 
see if the difference in alpha production by the various cell lines was 
due to differences in the synthetic pathway, the alpha protein 
synthesized by S-3 (a high producer) was compared with that of 2.1 (a 
low producer). Medium from 2.1 and S-3 cells was extracted with 50* 
dioxane (v/v), dialyzed against water, and precipitated with 90% 
(NH^ )2S0^  (w/v). The pellet was resuspended in O.Ol M NaKCO^ , 
lyophilized to dryness, and resuspended in 0.1 H SH^ HCO^ . These 
It* 
partially purified samples were co-chromatographed with " l-labeled 
urinary hCG-a over a column of Sephadex G-75 Superfine. The elution 
profiles show that the Hela-ei from both cell lines chromatographed 
similarly to each other and at a slightly higher apparent molecular 
weight than urinary hCG-a (Fig 4). Thus, there does not appear to be a 
significant difference in the overall size or shape of hCC-s in these 
two cell lines. 
Difference* in cne ectopic production of hCC by various tumors has 
been suggested to be related to the level of protein glycosylation 
(Yoshimoto et al., 1979). Since no difference in the size of HeLa-o 
produced by 2.1 and S-3 cells was observed, the carbohydrate composition 
125 
Figura 4. C-75 column ehromacography of Haia-o and I-laball«d hCC-ci. 
(BaU-a waa partially purifiad and co-chromacographad vieh 
^^ I^-laballad authaneie hCC-<s aa daacribad in eha e«xt. 
Fraction# of 2.5 ml vara collected and aacayed for Bela-a by 
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RIA. I-labelled hCC-dl wee detected by eolid scintillation 
spectroscopy. The amount of S-3 RaLa-fl applied to the column 
was 2465 ng and recovery was 94%. 1300 ng of 2.1 HeLa-a vas 
chromatographed and 89% was recovered. (A) S-3* (B) 2.1.] 
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of the two samples was examined by chromatography on lectin columns of 
Concanavalin A-Sepharose and Ricin-agarose. Con A binds 0-glucose and 
D'mannose residues while Ricin has a specificity for 0-galactose. 
Glycoproteins bind to these lectins because the carbohydrate structure 
of asparagine linked glycoproteins contain a high mannose core and 
terminal galactose residues. Medium from 2.1 and S-3 cultures was 
extracted with 50% dioxane Cv/v) and precipitated with 90% 
(w/v). The pellets were resuspended and chromatographed over 
Concanavalin A-Sepharose as described in Materials and Methods. The Con 
A elution profiles of these samples show that the majority of the alpha 
subunit synthesized by both cell lines bound to Con A. indicating that 
they are glycosylated (Fig 5). The peak of the S«3 bound material 
eluted in 18 ml of 0.2 H D-e-methylglucoeide while the peak of the 2.1 
bound material eluted in 13 ml. The Con A-bound material (2.1 fractions 
6S'87 or S"3 fractions 42*38) was pooled, dialyzed against water, and 
lyophilized to dryness. The lyophilized material was resuspended in 
water, desialylated (to expose the penultimate galactose residues of the 
carbohydrate side chains and thereby facilitate binding to ricin CEagon 
and Heath, 1977), and chromatographed on Ricin-agarose as described in 
Materials and Methmis (Fig 6). The similar chromatography of both 
saoules suggested that the HeLa-a synthesized by both cell lines were 
similar in their terminal glycosylation composition. From these lectin 
binding data, it was inferred that the difference in hCC«a production 
between 2,1 and S»3 does not result from a gross difference in 
glycosylation. 
Pi*ur# S. Goneaiwvslin A S«pharof« ehromaeotraphy of hCC-0 (rem KcLa 
S-3 and 2.1 call Una*. [Haia-a waa partially purifiad from 
eha BMdlifli of S«3 and 2.1 ealla and ehromaeotraphad on Con-
canavalin A Sapharoaa aa daacrlbad in Katariala and Haehoda. 
One ml fraetlona vara eollaetad and aaaayad for hCG-0 by RIA 
for eha 2.1 aaspla whila 2 ml fraetiona vara eollaecad for eha 
eha 8-3 aampla. Tha arrowa danoea alucion wieh 0.2 M 
C-maehyl glucoaida. Tha amount of HaW-a applied was 
3jwg of S-3 a and 3.1 |lg of 2.1 CI . Recoveries were 91% 
and 89% for S-3 and 2.1, reapecelvely. (A) Elueion profile 
for S-3 ReLe-0 . (B) Elueion profile for 2.1 Hela-0.) 
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Figure 6. Ricin agaro## chrcoacography ci d#*iaiylacad hCC-O from H«La 
S-3 and 2.1 medium. (The Con A bound HeLa-O from Fig 5 warn 
pooled, deaialylaced, and chromacographed over a column oi 
Ricin agaroae as deeeribed In Haeerials and Xechods. Arrows 
indicate the elution with 0.2 H D-galactose. Of the ng 
of S-3 KeLa-fl and the 1.0 ^  of 2.1 HeLa-0 applied to che 
column, about 97% and 80%, raapectivelv were recovered. 
fAlHela S-3 (B) Hd.., 2.1.1 
HeLa-a (ng/hnl) 
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Induction of hCG-a and PAP 
An alternative approach to examining the regulation of alpha and 
alkaline phosphatase production involved the use of agents which 
modified their expression. 
Determination of assay and culture conditions for PAP activity and hCG-a 
induction 
Since placental alkaline phosphatase is a membrane bound protein, 
the assay may depend upon the method of cell extract preparation. 
Addition of deoxycholate (0.2-0.5*) to the cell suspension during 
sonication enhanced the measurement of alkaline phosphatase activity 
about 2.5 fold (Fig 7). Equivalent levels of alkaline phosphatase 
activity in the crude sonicate and in the post centrifugation 
supernatant indicated that PAP was efficiently extracted from the plasma 
membrane by deoxycholate. From these data, it was decided to include 
0.5% deoxycholate during sonication and to assay the activity in the 
crude sonicate. 
Production of hCG-o by HeLa cells varied with the cell density (Fig 
S). In control cells, production was higher at low cell densities (2 x 
5 2 10 cells/25 cm ), but in response to 3 mtt butyrate, subunit synthesis 
7 2 
was stronger at high cell densities (1 x 10 cells/25 cm ). To optimize 
induction conditions, most experiments were performed with cultures at 
high cell densities. 
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Figure 7. OeceraiMClon of aonicacio* and aaaay condieiona for PAP 
activity in cell extracts. [Several oê confluent HeLa 
S*3 cultures were harvested, pooled» and divided into 0.8 =1 
aliquots. These samples were sonicated on ice in the presence 
of deoxycholate (DOC) from 0-1.0% (w/v). Alkaline phosphatase 
activity was assayed from either the crude sonicate or from 
sonicate cleared of particulate matter by centrifugation at 
27,000 % g for 20 min. Symbols: pre-centrifugation (A), 
post-centrifugation (O).1 
Figure S. Synthesis and secretion of 1*00-4% as a function of cell density. fHeLa S-3 cells were 
plated at a density of 1 % 10^  cells/lS flask. One set of flasks (control) were fed 
daily with fresh MENC and duplicate cultures were harvested every other day. A second set 
of flasks (butyrate) were fed every other day with fresh HEHC. Sodiun butryate (2 nH) was 
added to duplicate cultures in this second set and harvested 2 days later. Cell numbers 
were determined using a hemacytometer and hCC-A was assayed in the culture medium by RIA. 
Symbols: control (•), butyrate (Oi •1 
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Heat tnacttvatton of HeLa alkaline phosphatase 
As described in the Introduction, there are at least three 
different alkaline phosphatase isozymes in the human genome (Mulivor et 
al., 1978c; Badger and Sussman, 1976*, McKenna et al., 1979). Although 
the alkaline phosphatase in KeLa cells has been characterized to be 
predominately the placental isozyme (which is heat stable), heat labile 
alkaline phosphatase activity has also been reported (Benham et al., 
1978; Benham and Harris, 1979). It was of interest, therefore, to 
determine if the predominant isozyme in induced cells was the same as 
that in control cells. From the heat inactivation profiles presented in 
Fig 9. it appears that butyrate, BrdUrd, and cytosine arabinoside 
enhanced the activity of the major isozyme which is active in untreated 
cells. This isozyme had a heat inactivation profile similar to 
authentic PAP. Inhibition of the activity to 50% occurred at 7l°C for 
PAP and KeLa control cells, 72**C for butyrate and BrdUrd created cells, 
and 73*^ 0 for cytosine arabinoside induced accivity. Since ocher 
isozymes of alkaline phosphatase are inactivaced by heating ac 65*'c for 
30 min, a mixture of isozymes would be expected to result in a bi- or 
multi-phasic inactivation curve. 
Effect of butyrate concentration on a and PAP induction 
One mecabolice which greatly enhanced che production of hCG-s and 
PAP activicy in HeLa cells was sodium bucyrace. The effect of butyrate 
from I CO 20 mH on che expression of hCG-O and PAP is illustrated in Fig 
10. PAP activity increased proportionally to the butyrate concentration 
Figure 9. Heat Inaccivation profiles of alkaline phosphatase activity fro# Itela cell cultures. 
(«eU S-3 cells were grown for 3 days In lœNC alone (control) or in medium containing 
I mH hucyrace (*tr), 10 mN cytos) ^  arahlnoslde (Ara-C), or 10 ng/ml 4-bromodeo*y-
uridine (BrdUrd). Cells were hacvcstt^ d and sonicated in 1 mi of Trie saline buffer 
containing 0,5% DOC. Insoluble material was removed by centrifugatlon at 27,000 % g 
for 20 mln. Thet si^ ernatant was divided into O.l ml aliquot*, heated for 5 min at 
37 to 80 C, cooled on ice, and assayed for alkaline phosphatase activity. The 
activity of each heated sample is expressed as the percent activity compared to an 
unheated duplicate. Heat inactlvation profiles were compared to that of placental 
alkaline phosphatase which was obtained from Miles Laboratories (15 U/mg). In this 
experiment, butyrate induced alkaline phosphatase about 3.6 fold, Ara-C about 2.4 
fold, and brdUrd about 4.8 fold.| 
Alkaline Phosphatase Activity 
% of unheated aliquot 
09 
Figure 10. Induction of hCG-O and PAP by sodium butyrate. IHeLa S-3 cells were cultured to near 
2 
confluency in 25 c# flasks. Iliey were then fed with fresh IffiMC containing 0 to 20 
nH sodium butyrate. After 72 hr, the cells were harvested and assayed for PAP 
activity and hCG-Ot as described in Materials and Methods. Symbols: hCC-a (#), 
PAP (A,.I 
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up CO 3 mM, while higher concentrations were not as effective. The 
production of hCG-o was also proportional to the butyrate concentration 
with maximum induction occurring between 5 and 10 mM. This observation, 
that maximum induction of PAP occurs at a butyrate concentration lower 
than that required for maximum hCG*a production, is consistent with the 
idea that the expression of these two genes is not co-ordinately 
regulated. 
Synergistic induction of hCG«a 
In previous reports, the production of hC6 and hCG-a was enhanced 
by various potential modulators of cAMP levels in normal placental cells 
and in human malignant trophoblasts but not in three non-trophoblastic 
cell lines. ClCo, CaSki, and OoT (Kussa et al.. 1977. 1978). KeLa cells 
were not examined. Thus, it was of interest to investigate the possible 
involvement of cAMP in the synergism between butyrate and some of the 
inducers surveyed by Park (1981). In this regard, theophylline, 
thymidine, and cAMP were studied for their effect on induction by 
butyrate. Pronounced increases were observed with theophylline and 
thymidine (Fig II). Butyrate (3 iM) alone induced hCG-o about 6.8 fold, 
thymidine (300 wM) about 1.4 fold, and theophylline (I mM) about 1.8 
fold. In other experiments, theophylline occasionally induced hCG-a 
comparable to butyrate alone; the reason for this is not known. 
However, the combination of butyrate and thymidine resulted in a 15.5 
fold induction of hCG-*. while butyrate and theophylline resulted in a 
30.8 fold induction. PAP activity was induced sligktly by butyrate or 
Figure 11. Effect of thymidine and theophylline on bucyrate-
mediated induction of hCC-<% and PAP. (HeLa S-3 cells were 
grown in the presence of 3 mM butyrate, jUU /jn thymidine, 
1 mM theophylline, and 1 mM cAMP according to the induction 
protocol in Material and Methods. (A) The concentration of 
hCG-a in control cultures was 236 ng/mg protein. (B) PAP 
activity in control cultures was 30.6 mU/mg protein. 
Cultures treated with butyrate are denoted by the solid bars.) 
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chymidino alone, while theophylline appeared to inhibit PAP activity. 
Synergism was not observed with the butyrate and thymidine combination 
or the butyrate and theophylline combination. Cyclic AMP (cAflP) did not 
induce either protein. The combination of cAMP and theophylline induced 
hCG*a only 6.2 fold and did not enhance PAP activity. 
Although the methylxanthines caffeine and theobromine are also 
known to increase cAMP concentrations, synergism with butyrate was 
specific for theophylline. Table 111 shows that 1 mM theophylline, but 
not 1 mM xanthine. 1 mM caffeine, nor 1 mM theobromine, was synergistic 
with butyrate for the induction of hCG-a. All of the xanthine compounds 
inhibited the butyrate induction of PAP. These data suggest that 
theophylline mediates its synergistic effect with butyrate by a 
mechanism other than an increase in cAMP levels. Also, the synergistic 
induction of hCG-a and the inhibition of PAP induction suggests 
discordant regulation of these two proteins. 
The time course of hC6«a accumulation by cells treated with 
thymidine and theophylline alone or in combination with butyrate is 
presented in Fig 12. Alpha levels did not increase over control values 
until 48-72 h after the addition of Thd to the medium. In this 
experiment, as well as most others, the induction of e by the 
combination of Thd and Btr was additive or slightly synergistic. 
Theophylline induced hCG-o to approximately the same extent as butyrate 
for at least 48 hours. In contrast, cells treated with butyrate and 
theophylline exhibited a levels increased relative to control after only 
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Table III 
Effect of xanthine and xanthine derivatives on the butyrate 
induction of hCC-Ct and PAP° 
Values 
II 
Fold Values 
PAP 
Mean Fold 
Sample ng/r ng protein induction mU/mg protein induction 
Control 0.58. 0.68 0.63 l.O 0.15, 0.17 0.16 1.0 
Xanthine 0.58. 0.26 0.42 0.7 0.15, 0.13 0.14 0.8 
Caffeine 0.99. 0.88 0.94 1.5 0.09, 0.10 O.IO 0.6 
Theobromine 0.85, 0.51 0.68 I.I O.ll, 0.10 O.ll 0.6 
Theophylline 1.3. 1.2 1.2 2.0 O.tt, 0.10 O.ll 0.6 
Butyrate 4.5. 2.7 3.6 5.8 8.4, 5.7 7.1 48.8 
Butyrate 
Xanthine 1.8. 3.8 2.8 4.4 2.7, 3.8 3.2 20.2 
Butyrate 
Caffeine 4.7. 4.8 4.7 7.5 1.8, 2.3 2.0 12.8 
Butyrate 
Theobromine 6.1. 4.9 5.5 8.8 2.7, 2.8 2.8 17.4 
Butyrate 
Theophylline 13, 19 16 25.4 2.2, 2.1 2.2 13.6 
e^ta 2.2 cells in 25 em flasks were treated with I nM xanthine, 
t mM caffeine, I mK theobromine, or I mM theophylline alone or in 
combination with 3 mM butyrate for 3 days. Cells were harvested and 
assayed for hCCWS as described in Materials and Methods. PAP activity 
was assayed from either 100 *1 or 50 #1 of the cell sonicate in a total 
volume of I ml containing 0.75 M 2-amino-2-methyl*l^ propanol, pH 10.7, 
and 8 ndt p-nitrophenylphosphate. The reaction was monitored by measur­
ing the in a Becknan 2400 OU Spectrophotometer using a Gilford 6051 
chart recorder and the automatic cuvette changer. The cuvette chamber 
temperature was maintained at 37 C by means of a circulating water bath. 
The mK extinction coefficient of p-nitrophenol was determined to be 18. 
Assays of duplicate cultures were within IZ to 40% of the mean. 
Figure 12. Tim# cours# of hCC-aaccumulation in r«spons« co chymldin#, 
2 
chaophyllin#, and bueyrae#. (HeLa 2 .2  colls in 75 cn flasks 
ae n«ar conflusncy u«r# grown in 2 mM chynidin#. 1 mM 
chaophyllln#, or 3 mM bucyrae# as indicacco below. Ac 12. 
24, or 48 h after ch# addition of effectors, 1 ml aliquots 
were removed from the medium and analysed by RIA. Cells were 
harvested after 72 h for protein determination. Symbols: 
control (•), Thd (A), theophylline (•). Btr (O), Str + Thd 
(A), Btr theophylline (w-l 
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12 hours. Subsequent synthesis continued at a rate higher than that 
with butyrate or theophylline atone. Thus, the combination of butyrate 
and theophylline stimulated the production of hCG-a earlier than either 
compound alone, reducing the lag time by about 12 h. These data also 
suggest that theophylline and thymidine are interacting with butyrate to 
stimulate a production via different mechanisms. 
Ectopic protein induction ^  thymidine, bromcdeoxvuridine. 
fluorodeoxvuridine. and iododeoxvuridine 
Many of the agents observed to induce ectopic proteins in HeLa 
cells are compounds which inhibit nucleotide metabolizing enzyiMS or are 
themselves modified deoxynucleoside» (Park, 1981). As such, a number of 
these have proven to be useful chemotherapeutic agents (e.g. 
fluorodeoxyuridine, hydroxyurea, bromodeoxyuridine, cytosine 
arabinoside). 
A study of the concentration effect of the deoxynucleoside analogs 
thymidine, bronodeoxyuridine. fluorodeoxyuridine. and iododeoxyuridine 
on the induction of hCG-e and PAP produced curves similar to those for 
butyrate (Fig 13). That is. the induction of hCG-a and PAP was dose* 
dependent, with maximum PAP production occurring at a lower 
concentration of inducer than maximum hCG-o induction. Concentrations 
which gave maximum induction of PAP and alpha subunit were 100 uH and I 
mM respectively for IdUrd, 30-100 wM and 300 wM for BrdUrd, and 300 uM 
and 2 mM for Thd. The results obtained with FdUrd reflect the 
Figura 13. Induction of hCC-Cl and PAP by chymidin#, iodod«oxyuridin«. 
fluorodooxyuridine, and broaod«oxyuridin«. (H«La S-j cell# 
w#r# grown in ch# pr###nc# of 1/jN co 2 oM Ihd. IdUrd, 
FdUrd. or BrdUrd according co ch# induccion proeocol in 
Macsrials and Mochods. The resulcs are ploceed a* the 
fold induceion of concrol culcures which concained (A) 
6.9 sU/mg protein for PAP activity and (B) 302 ng/mg 
protein for hCC><V . Symbol*: Thd (A). IdUrd (•). FdUrd 
(%), BrdUrd (â).) 
fold induction PAP fold induction 
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cytotoxicity of this compound as indicated by the cell necrosis and 
death in cultures containing at least 3 uM. These results are a further 
indication that there are differences in the regulation of alpha and PAP 
gene expression. 
The kinetics for protein induction in response to these 
deoxyuridine derivatives is illustrated in Fig 14. In general, it took 
longer for cells co respond to the deoxyuridine compounds than to 
butyrate. The carboxylic acid induced hCG-a and PAP between 12 and 24 
hours after addition and supported higher protein levels than those 
realized with any of the deoxyuridine derivatives. lododeoxyuridine 
induced hCG-a between 24 and 48 hours after addition while thymidine and 
bronodeoxyuridine induced hCG-o between 48 and 72 hours. The time 
course of induction of PAP was less clear. The increase in enzyme 
activity in response to IdUrd and butyrate were similar for at least 48 
hours. The former showed a slight decrease in activity at 72 hours. 
Thymidine induced PAP between 24 and 48 hours and BrdUrd did not induce 
PAP in this experiment. 
Inhibition of induction bjj deoxvcvtidine 
In a recent report, Goz et al. (1980) reported that deoxycytidine 
inhibited the induction of PAP by IdUrd, butyrate, hydrocortisone, and 
choline chloride in Hela cells. Along with dCyd, other nucleosides 
including thymidine, cytidine, and cytosine arabinoside inhibited the 
induction of alkaline phosphatase by IdUrd in a dose dependent manner. 
While these results may be explained by an expansion of thymidine pools 
Figure 14. Tine course of **CC-ci and PAP induction by butyrate, IdUrd, Thd, and BrdUrd. lUeLa 
S-3 cells were grcwn to near confluency and refed with fresh HEMC or MEMO containing 
3 mH butyrate, 100 #M IdUrd, 100 BrdUrd, or i mM Thd. Following these additions, 
cultures were harvested at 1, 5, 12, 24, 48, and 12 h and assayed for hCC-Oi and PAP 
as described in Materials and Methods. Symbols: Control (•), Btr (D), IdUrd (•), 
Thd (A), BrdUrd (A) .) 
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to dilute the incorporation of IdUrd into ONA, the correlation between 
IdUrd incorporation and alkaline phosphatase induction was non-linear. 
From these data, Cos et al. suggested that incorporation of IdUrd into 
DMA was not required for alkaline phosphatase induction and that 
cytidine and dCyd had another, undefined, locus for the inhibition of 
alkaline phosphatase induction. The effect of dCyd on a induction had 
not previously been examined. Consequently, it was of interest to 
determine whether dCyd had an effect on the induction of PAP and hCC-a 
by the various agents under investigation in the present study. Table 
IV shows that, in general, 2 mM dCyd inhibited the induction of both PAP 
and hCG-o. The exception may be the induction of hCG-o by butyrate or 
hydroxyurea, where no inhibition by dCyd was observed with butyrate 
alone. Furthermore, partial Inhibition was observed with hydroxyurea 
alone or when butyrate was combined with another inducer. Comparison of 
the effect of dCyd on butyrate between the two experiments reflects the 
variability observed, with the data of Experiment I representative of 
the majority of cases. A t test analysis of the effect of dCyd on the 
Btr induction of PAP and hCG-a gave a t value of 1.46 with p 0.084 and 
a t value of 0.31 with p > 0.25, respectively. These data suggest that 
dCyd may be affecting a process common to the induction of PAP and hCG-o 
but that when butyrate is present, the induction of hormone subunit is 
less sensitive than is that of PAP. To study this further, experiments 
were concentrated on the effect of dCyd on the butyrate induction of 
hCG-a and PAP. 
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Table IV 
Effect of deoxycytidine on the Induction of hCG-<% and PAP* 
Sample PAP hCG-tt 
Experiment I mU/m* protein ng/mg protein 
Control 8.6 i 8.3 (24) 226 t 122 (22) 
dCyd 2 mM 7.8 i 6.3 (15) 220 t 131 (14) 
Btr 3 mM 24 t 24 (24) 1460 t tOtO (22) 
Btr + dCyd 14 i 11 (16) 1300 S 20W0 (16) 
Experiment 11 fold induction fold induction 
Control t.O t.O 
dCyd I mM 0.5 1.2 
Str 3 mM 3.7 9.0 
Btr + dCyd 2.7 17.8 
BrdUrd 0.1 mM 1.6 6.7 
BrdUrd + dCyd 0.8 1.9 
IdUrd O.l mM 2.1 5.4 
Idlfrd + dCyd l.O 1.6 
Btr + IdUrd 3.7 19.2 
Btr + IdUrd + dCyd 2.1 25.3 
Thd 0.3 mM 1.7 10.9 
Thd + dCyd 0.8 1.8 
Btr + Thd 3.5 26.1 
Btr + Thd + dCyd 1.8 16.2 
Theophylline 0.8 9.6 
Btr + theophylline 2.7 58.7 
Btr + theophylline + dCyd 1.4 35.0 
hydroxyurea 1.2 8.4 
hydroxyurea + dCyd 0.8 5.1 
5-3 cells in 25 cm flasks were grown as described in Materials 
and Methods. In Experiment I, the number of replicates is given in paren­
thesis. Control values were 502 ng/mg protein for hCGHX and 12.8 nU/mg 
protein for PAP in Experiment II. 
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Fig IS shows Che dose-response for dCyd on the induction of PAP and 
hCG-a in the presence and absence of butyrace. While the Induction of 
both PAP and hCG-a was inhibited by dCyd, PAP was more sensitive than 
hCG-a. That is, the concentration of dCyd (2 mM) which inhibited PAP 
induction by SO* was half the concentration (4 mM) which inhibited the 
hCG-a induction by S%. 
The effect of dCyd on the time course for butyrate induction of PAP 
and hCG"* is shown in Fig 16. The alpha subunit was induced 12 to 24 
hours after the addition of butyrate in both butyrate and Btr/dCyd 
treated cells; production rates remained similar for 48 hours but 
decreased slightly between 48 and 72 hours in Btr/dCyd cultures. In 
contrast, PAP was induced 24 to 48 hours after the addition of butyrate 
and this increase was abolished completely when the cultures were 
supplemented with 2 mM dCyd. The inhibition of PAP and hCG-e did not 
result from a general cytotoxic effect on the cells (Table V). 
Oeoxycytidine inhibited DMA synthesis completely, UNA synthesis only 
slightly, and bad little or no effect on protein synthesis. Based on 
work by others in this laboratory, the degree of RNA synthesis 
inhibition was not considered to be sufficient to account for the 
inhibition of PAP induction. 
There are several mechanisms by which dCyd might alter the cellular 
response to butyrate. The nucleoside might somehow interfere with the 
uptake or metabolism of the fatty acid and thereby inhibit protein 
14 induction. Consequently, the incorporation of |C) butyrate in the 
figurt 13. Efface of daoxycycidio# on th« bucyraca induction o( nUG-O 
and PAP. (HaU 2.2 call# in 25 cm^  flaaka vara grown in 
dCyd alona (1 co 4 mN) or in combination with 3 oM butyr-
ata. Culturas wara harvastad 72 h latar and aaaayad for 
PAP and hCG-d aa daacrlbad in Hatariala and Maehoda. Con­
trol valuaa wara (A) 0,56 mU/mg procain for PAP and (B) 
328 ng/mg protain for hCG-0. Butyrata induead hCG-O 
about 4 fold and PAP about 19.4 fold. Cultures grown in the 
absence or presence on butyrat# ar» represented by the closed 
(•A) or open OA) symbols, respectively.) 
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Figure 16. Effect of dCyd on the time course of Induction ji PAP and 
hCG-a by butyrate. {HeLa S-3 ceil# were grown In HEMC alone 
(Control) or HZKC containing J aM butyrate and/or 2 mM dCyd. 
Cultures were harvested at 6, 15. 24, 68. and 72 h and 
assayed for (A) PAP and (B) hCC-ci . Sv^ b^ols: Control 
(•). dCyd (•). Btr (O). Btr + dCyd (01.1 
82 
hours 
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Table V 
Effect of deoxyeytidina on DMA* RNA, and protein synthesis* 
Sample )^ cfomolecular Synthesis 
Dm RNA Protein 
Control 100 100 100 
+ dCyd (fflH) 0.1 10 72 81 
0.3 4 68 68 
I U 62 92 
• 2 3 63 99 
Butyrate 48(100) 129(100) 171(100) 
dCyd (oM) 0.1 h( 13) 104( 81) 129( 74) 
0.5 6( 13) 88( 68) 122( 70) 
I i( ID 78( 61) 128( 73) 
2 4( 9) 63( 49) 128( 73) 
e^U S-3 cells in 24 well culture flasks were created wlch dCyd 
alone or in combination with bucyraee (3 nM) for 3 days. Individual 
wells were labeled vitb C^ B] thymidine or I^ Bl uridine and amino 
acid mixture for 4 h. The samples were harvested and assayed as 
described in Materials and Methods. Control values were 1.66 x 10^  
3 4 
cpm/m$ protein for { H) thymidine incorporation, 3.15 x 10 cpm/ng 
protein for uridine incorporation, and 1.92 % 10^  cpm/mg protein 
for (^ C^l amino acid incorporation. 
absence and presence of dCyd was investigateo. Table VI shows that dCyd 
alone did noc inhibit the cellular incorporation of butyrate at 9 or 30 
hours after the addition of dCyd. 
To determine if an inhibitor of PAP was present in dCyd treated 
cells, sonic extracts of cells cultured for 72 h with 3 mM butyrate, 2 
mM dCyd, or Btr/dCyd in combination were mixed together in different 
ratios and assayed for alkaline phosphatase activity. The observed 
activity was compared with the values expected to be present based on 
Che ratio of each sonicate (Table VII). The nearly identical values for 
observed and expected activity suggested that a freely diffusible 
inhibitor of alkaline phosphatase activity was not present in dCyd 
treated cells. Deoxycytidine also did not have a direct effect on 
commercially available PAP or PAP partially purified from HeLa or human 
placenta (data not shown). 
The inhibition of PAP induction by dCyd can be prevented by 
preincubating the cells with butyrate (Fig 17). Addition of 2 mM dCyd 
within 6 h of the addition of butyrate inhibited the induction of PAP 
activity. However, if the cells were exposed to butyrate for II h 
before the addition of dCyd. an inhibition of PAP activity was not 
observed. Thus, dCyd interferes with an early event of butyrate 
induction. This event occurs within 6 to 11 h after the addition of 
butyrate and it is resistant to the subsequent addition of dCyd. 
Preincubation with butyrate bad little effect on the induction of hCG-a. 
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Tabltt VI 
Efftce of dCyd on eh* incorporation of f^ C^l bueyr«e« into H#La 
cell#* 
14 ( C) bucyrace incorporation 
Sampl# cpm/10^  calls 
9 h 30 h 
Control 4500 3100 
dCyd 30 4900 3300 
100 nii 5300 3100 
2000 kM 4900 3700 
®h«La S-3 cells were grown in 24-well titer places In the presence 
ol 30 j#M, 100 tiHt and 2 mM dCyd. After either 7 or 28 h, the cells were 
labelled with 1 ttCl of butyrate for 4 h. The cells were harvested, 
collected on Millipore filters, and counted in a liquid scintillation 
eluor. 
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Table VII 
PAP activity in aixturtts of c#ll aonicac*** 
Rat:J of 
sonicacu» 
PAP 
mU/ml 
Btr/dCyd : Btr 
dCy Btr 
Obaarvad 
9.)j 
11.:: 
13.21 
n.73 
17.oj 
13.21 
13.91 
15.55 
17.02 
17.63 
Exptctad 
9.33 
11.40 
13.48 
15.56 
17.63 
13.21 
14.31 
15.42 
li.52 
17.63 
*Sontc extracts of cell* i&rown In 3 nM butyrate were mixed with 
those of cells grown in 2 stM dCyd or butyrate plus dCyd. After 30 
ssin on ice, the sampler were assayed for alkaline phosphatase 
ictivity. The observed PAP was compared with the activity expected to 
Ue present based on the ratio oc the sonicates. 
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Figure 17. Preineubaeion wlph butyraee before ehe addieion of dCyd. 
CHeLa S-3 cells were fpd wich 3 oM bueyraee ae eine zero. 
Devxycyeidine (2 nH) was added subsequene eo bueyraee ae 
0, 3, 6, 11, 20, and 24 h. The cultures were harvested 
after 72 h and amsayed for PAP activitv and hCG-O as 
'•?s.:rtb<#d In Haeeriat» and >Jechod;». fU«: fe=yL: ;r- >. •<'--
relative to the levels .>bcato»;â tn .-uUurcs rs.ci'/tng off 
plua dCyU at time zero; I.e., zc -ich Sif. 
Control values were 99 ng/mg protein for UCC-a and 2.1 
mU/ng protein for PAP. Sywhoi®; paP (Q). ncn-a (#), 
Control (OorB>. Stt * A r Wk) levels f'>r PAP (0,A) 
and hCC-a («.AJ respectively.) 
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Butyrate mediates numerous changes in cellular membranes, such as 
the induction of sialylytransferase I and cholera toxin receptors 
(Fishman et al., 1974; Fishoan and Atikkan, 1979). Also, Wharton and 
Goz (1978) and Hung and Melnykovych (1976) reported that choline and 
lysophosphatidylcholine respectively stimulated PAP activity in HeLa 
cells. Since the nucleotide derivative CDP-choline is an intermediate 
of phosphatidylcholine synthesis, the effect of butyrate and dCyd on the 
14 incorporation of ( C) choline was examined. During the initial 36 
hours of exposure, butyrate inhibited the incorporation of choline but 
dCyd did not reverse this inhibition (Fig 18). 
Other deoxynucleosides in addition to dCyd inhibited the butyrate 
induction of PAP activity (Table VIII). Deoxyadenosin* and 
deoxyguanosine inhibited hCG-o and PAP induction at 2 mH but not at 100 
WM. Deoxycytidine inhibited the PAP induction at 2 mM but not at 100 
and did not affect hCG«a induction at either concentration. Thymidine 
did not affect the induction of PAP and was slightly synergistic with 
butyrate for the induction of hCG's. It appears that, in general, 
purines are more effective inhibitors of the butyrate induction of PAP 
activity and hCG'S than pyrimidines. 
Inhibition of DMA synthesis 
Since protein induction has been postulated to be correlated with 
the inhibition of DNA synthesis (Ghosh et al., 1977), it was of interest 
to determine the effect of the compounds used in this study on DNA 
synthesis. It was of particular interest to see whether the antagonism 
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Figure 18. Sffecr of dCyd on chi tnc irp -r uf [ Cl »lu.! i 
(HeW S-3 cell# were grown in 24-well cluster plates in the 
presence oc dCyd alone or in combination with i ntft Str. 
Cells were labelled for 4 h with 1 #C1 of (*^ C) choline at 
8, 22, and 34 h after Btr and/or dCyd addition, har/ested. 
collected on Hillipore filters, and counted in a liquid 
scintillation fluor. Symbols: Control (•), 100 uH dCyd 
(•). 500 dCyd (•). 2 nM dCyd (A), 4 mM dCyd (X). Btr 
(V), Btr * 100 itH dCyd (O). Btr + 500 <iM dCyd (D), Btr + 
2 mM dCyd (A*. ) 
sjnoM 
06 
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Table VIII 
Efface of daoxynuclaotidts on eh# butyratc induction of hCH-ci 
and PAP* 
Fold tnduceton 
Sampl# hCC-a PAP 
Control l.O 1.0 
dCyJ 0.1 BM 1.0 0.9 
2 BM o.s 0.9 
Thd 0.1 oM 0.0 O.i 
2 oM 1.7 1.7 
dAdo 0.1 BM 0.5 0.6 
2 M 0.6 1.0 
dCuo 0.1 BH 1.0 0.9 
2 BM 0.3 0.» 
Btr 3 mM 3.0 29.; 
3cr + dCyd 0.1 mM 2.8 27.3 
3tr + dC'/d 2 BM 4.3 15.1 
3tr *• Thd 0.1 mM i.O J8.8 
9tr * Thd 2 mM 5.3 33.0 
5tr + dAdo 0.1 mM 2.5 33.4 
Btr + dAdw 2 =#* 1.9 13.0 
3tr * dCuo 0.1 mM 3.1 31.8 
Btr + dCuo 2 mM 0.8 3.4 
<£.2 calls l« 25 ca" flasks were created with deoxynucleo-
%tdes alone or tn conblnacion with Btr for 3 days. Cells were harvested 
and amsaved for UCC-CI nw duserfhed In Materials and Methods. PAP activity 
vas meabared as described in Table III. The vas recorded manually 
4t I to 2 tain intervals. The non-enzymatic hydroisis of p-nitrophenyl-
.jnosphdLe .^aa d^termineU usin^ I'lfi itl or water insiaad ot cell sonicate. 
* mM extinction cuefflcivnt of 13 was used for p-nicrophenol (see Tabla 
HI). Control values were I.I' wg/ag protein for hCC-a and 0.61 mU/m% 
protein for PAP, 
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between dCyd and other inducers could be explained, in pare, by a 
reversal of the DMA synthesis inhibition. Table IX shows that most of 
the compounds inhibited the incorporation of radiolabeled precursors 
into TCA precipitable material from 60"60% compared to control levels at 
concentrations which affect ectopic protein expression. Those compounds 
which did not inhibit DMA synthesis as strongly included 1 mM 
theophylline. 2 mM dCyd, Thd (1-2 mfl), 1 mM IdUrd, 3 mfl hydroxyurea, and 
possibly the combination of butyrate and theophylline. The difference 
in the data between the two butyrate plus theophylline combinations may 
reflect the difference in how the experiments were done (Incubation with 
effectors for 24 h vs. 3 days prior to isotope addition; different 
radiolabeled precursors). Combination of effectors enhanced the 
inhibition of DMA synthesis. The addition of dCyd did not reverse the 
inhibition of DMA synthesis. By comparing the inhibition of DMA 
synthesis with the induction of a and PAP (Figures 10, 11, and 13; Table 
IV). there does not appear to be a correlation between the degree of 
induction and the inhibition of DMA synthesis suggesting that these two 
events are independent of one another. 
Levels of cAHP 
While the cAftP (Fig U) and methylxanthine data (Table III) suggest 
that cAMP is not involved in the production of hCG-a and PAP, 
measurement of intracellular cAMP levels under a variety of culture 
conditions should help to clarify the situation. The intracellular 
level of cAMP was measured in cells grown under various induction 
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Table IX 
Efface of Inducer# on ONA synehesis 
Percent of control 
Sample Thd dAdo 
Experiment I 
Control 100 100 
Ber 49 65 
dAdo 2 oM SO 
Btr dAdo 43 
dCuo 2 mM 21 
Btr * dCuo IS 
theophylline 1 mM 89 
Ber * theophylline 74 
dCyd 78 
Ber * dCyd 32 
Thd I oM 86 
2 mM 68 
Ber + Thd 2 mM 27 
IdUrd 1 ah 84 
2 mM 49 
BrdUrd I mM 47 
2 mM 52 
Experiment 11 
Conerol 100 
HU 3 mM 66 
dCyd 2 mM 32 
Btr + dCyd 52 
mi + dCyd 54 
Ber + HU 44 
Ber + HU • dCyd 28 
theophylline 105 
Btr + theophylline 
Experinene I. H«U 2.2 cells In 24 well culture dishes were 
grown under the experimental conditions for 24 b and labelled with I pCi 
[^ 1 Thd or 1 Ci dAdo for 4 h. The medium was removed by aspira­
tion and 0 5 ml of 0.3 M KOB was added to each well. After 20 to 46 h at 
room temperature, the KOB extract was neutralized with 150 fiL of I H HCl. 
A 50 uL aliquot was removed for a Lowry protein determination and the 
rest of the sample was precipitated with I ml of ice cold 10% TCA for 30 
min. collected on Mlllipore nitrocellulose filter, dried, and counted in 
liquid scintillation fluor. Control values were 3900 cpm/mg protein for 
thd incorporation and 912 cpm/mg protein for (^ Bl dAdo Incorporation. 
In Experiment II, cells were harvested and assayed after 3 days growth as 
described in Materials and Methods. Control value was 2.49 x 10 
cpm/mg protein. 
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conditions (Tabla X). Although the level of cAMP differs from one 
condition to another, the magnitude of the changes does not seem to be 
sufficient to account for the induction of proteins or the inhibition of 
PAP induction by dCyd and theophylline. Theophylline increased cAMP to 
similar levels by itself and in combination with butyrate, but 
production of hCG-a was 11 fold greater in combination with butyrate 
(Fig 12). The combinations of Btr/dCyd and Btr/Thd also had comparable 
levels of cAMP. However, Btr/Thd cultures had higher levels of a than 
Btr/dCyd and the butyrate induction of PAP was inhibited by dCyd but not 
Tbd. Coupled with the cAMP and methylxanthine addition experiments, 
these data support the view that the synergism between theophylline and 
butyrate for the induction of hCC's involves a mechanism other than cAMP 
production. 
Deoxvnucleotide levels in control and butyrate cells 
Most of the effectors of ectopic protein synthesis used in this 
study were nucleoside compounds. In other systems, the addition of 
excess deoxynucleosides profoundly altered endogenous pool sizes 
(Snyder. 1984; Cohen et al., 1983). To determine if butyrate also 
affected the concentration of deoxynucleotides, acid soluble extracts of 
control and butyrate treated cells were assayed for deoxynucleoside 
triphosphates as described in Materials and Methods. Control cells 
contained about 36.4 pmoles dATP/mg protein and 8.0 pmoles dTTP/mg 
protein. Butyrate-treated cells contained about 14.6 pmoles dATP/mg 
protein and 6,2 pmoles dTTP/mg protein. The levels of dCTP and dGTP 
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Table X 
Effect of protein Inducers on the levels of cAXP* 
CAMP 
Sample (pnoles/mg protein) 
Control 2.31 
dCyd 2.40 
Btr 2.40 
Btr + dCyd 3.16 
theophylline 3.87 
Btr + theophylline 4.14 
Thd 2.71 
Btr + Thd 3.13 
e^la 2.2 cells in 7S ca flasks were treated with 2 mM dCyd, I mM 
theophylline, 2 mM Thd. alone or in combination with 3 mM Btr for 3 
days. Tb« cells were harvested and assayed for cAHP as described in 
Materials and Methods, 
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ware not detectable in either control or butyrate treated cells. This 
decrease in dATP and dTTP may reflect the inhibition of cell growth 
mediated by butyrate, possibly resulting from or leading to the 
inhibition of DMA synthesis, but it is unclear whether the levels of 
dATP, dTTP, or other deoxynucleoside triphosphate is significant to the 
expression of ectopic proteins. 
Detection of hCG-a transcripts in cytoplasmic extracts 
Although there are many possible sites to regulate gene expression 
in eukaryotes, the most frequent level of control appears to be 
transcriptional (Darnell, 1982). To assess the possible transcriptional 
regulation of a, the effect of various inducers on the levels of u-mRNA 
was examined using the cytoplasmic dot hybridization technique described 
by White and Bancroft (1962). Messenger RNA in cytoplasmic extracts was 
32 immobulized on nitrocellulose and hybridized to P-labeled *-cDNA 
probe. The level of hCG*a transcripts in each sample was reflected by 
the density of the autoradiograph emulsion (Fig 19), Although the 
densities are very similar for many of the samples, there may be a 
slight increase above the control samples in the extracts of cells grown 
in butyrate. theophylline, and IdUrd. A significant difference in the 
densities was present in those cells with greatly enhanced rates of 
hCG-a protein production (Btr/theophylline: Btr/BrdUrd; Btr/ldUrd; 
Btr/KU). Scanning the autoradiograph with a laser densitometer and 
comparing the relative densities of each sample with the corresponding 
fold increase in hCG~o protein production supports these observations 
Figure 19. Detection of hOG-O #RNA by cytoplasmic dot hybridization. iHeLa S-3 cells were 
grown in the presence of 3 *M Btr, 2 #M dCyd, Btr * dCyd. 1 «H Idtlrd. Idlird * dCyd. 
Btr + IdUrd, 300 ijH BrdUrd. BrdUrd + dCyd, Btr + BrdUrd, 2 aN Thd^  Btr + Thd, I aH 
theopltylline, Btr + theophylline, 3 #M lOJ, and Btr + UU according to the induction 
protocol described in Materials and Methods. The filters were probed with 
8 
nick translated a*clWA (14 * 10 cp# / jfg). Samples were diluted 1/50 
in column I, 1/15 in colutMt if, i/7.5 in column 3, and 1/5 in column 4. A and B 
refer to two separate experiments. |
Con A 
Btr A 
dCyd A 
Btr/dCyd A 
Thd 
theophylline 
IdUrd 
IdUrd/dCyd 
HU 
BrdUrd 
Con B 
Btr B 
dCyd B 
Btr/dCyd B 
Btr/Thd 
Btr/theophylline 
Btr/ldUrd 
Btr/BrdUrd 
Btr/HU 
BrdUrd/dCyd 
1 2  3  4  
wesf' 
™ '^PlPiP' 
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(Table XI). Since the densities of the autoradiograph emulsions depend 
on the length of exposure as well as the amount of bound radiolabeled 
material, differences in the scanning data between the darkest spots and 
the control samples may be minimum values due to over-exposure. 
However, a plot of the data in Table XI (omitting the Btr + theophylline 
values) generates a curve with a linear regression correlation 
coefficient of 0.92 (Fig 20). Hence, these data suggest that, in 
general, increases in a subunit correpond to increases in o-mRNA. 
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Table XI 
comparison ot ooc ctloc incsnsicies wich inàuccion of protein* 
Saoplt Fold'Induceion 
rtlacivff 
Control A and B 
Bcr A 
B 
dCyd A 
B 
Btr + dCyd A 
B 
BrdUrd 
BrdUrd * dCyd 
Bcr BrdUrd 
XdUrd 
Idl'rd 4. dCyd 
Bcr + IdL'rd 
Thd 
Bcr * Thd 
Theuphyi ; « fl­
eer V Theophvlline 
Hydroxyurea 
Btr + m 
*Th« doe blot sutoradiograph (fl; 19) waa acanitad with a Zeineh 
0ofe laaar «canning dtnaieomttr (1KB Znatr) at two gain eattiag* (2 
and 9). Th« relative density of each spot vas corrected for the 
dilution of the original sample and normalized to the amount of total 
cellular protein. Since these values varied from the lowest to the 
highest dilution, the value of a sample at a particular dilution (1/50, 
1/15, 1/7.5, or 1/5) was divided by the average of the two control 
(A and B) values at that dilution. The numbers generated by this 
method for a specific sample were averaged and are listed above. No 
values are given for Btr + dCyd B because the aliquot used for the 
protein determination was lost. The amount of hCG«a in the medium 
was assayed by RIA as described in the Materials and Methods, 
normalized to the amount of total cellular protein, and divided by the 
average of the Control level. 
O-mRNA normalized 
film intensity hCGrOl proteir 
1.00 1.00 
1.4% 6.5 
:.22 8.6 
0.23 0.59 
0.33 0.93 
1.08 5.43 
0.78 1.52 
1.47 1.54 
5.99 16.3 
2.03 3.88 
1.92 2.32 
8.80 18.90 
0.21 2.15 
3.28 11.49 
0.8b 2.96 
7.44 100.69 
2.93 2.41 
6.38 14.60 
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Figure 20. Comparieoo of alpha protein and mRNA induction. {Data 
of Table XI is presented graphically. Btr + theophylline 
sample was not plotted. The line was drawn by linear 
regression, with intercept. 0.87; slope, 2.Z; correla­
tion coefficient, 0.92.J 
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DISCUSSION 
Variation in the constitutive production of hCG-a and PAP activity 
among KeLa cell lines as observed in this study (Table I) confirms 
observations made by others (Chou et al., 1977; Lieblich et al., 1977; 
Lieblich et al.. 1976). However, the reason for this variation is 
unknown. From the initiation of transcription to the secretion of hCG-a 
into the medium or the insertion of PAP into the plasma membrane, there 
exists a number of possible sites of regulation. The similarity in size 
and apparent carbohydrate composition of the a-subunits synthesized by 
HeLa 2.1 (a low producer) and KeLa S-3 (a high producer) suggest that 
differences in their level of subunit production is not due to 
differences in the glycosylation mechanism (Fig 6-Fig 7), This is in 
contrast to work by Cox (1981c), who observed that the majority of 
desialylated HeLa-a from 2.1 medium did not bind to a column of Ricin-
agarose, suggesting that the protein was deficient in terminal 
carbohydrates and different from the hCG-@ produced by HeLa 2.2, The 
basis for this is unknown, but may reflect differences in the sample 
used for chromatography. Whereas Cox chroMtographed dialyzed but 
unfractionated medium, the material used in this study for Ricin 
chromatography was partially purified and bound to a column of ConA 
Sepharose. These purification and chromatographic steps may have 
selected for material which would bind to Ricin. If such a partitioning 
occurred, samples examined in the previous study may have been more 
resistant to desialylation, possibly due to differences in the 
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carbohydrate compoeicion (t.g., fucose residues in addition co or in 
lieu of sialic acid). Ic has also been observed chae coneinuous culture 
of 2.1 cells leads co an increase in hCv-O production (unpublished 
observations). Thus, the difference may reflect the collection of 
medium from cells at different lengths of continuous culture. That is, 
hCG-a Way be deficient tn terminal carbohydrates when production is low 
but complete in terminal carbohydrates as production increases. A 
correlation between giycosylation and the production of hCO-a would be 
consistent with the previous report (Cox, 1981c) and work by Yoshimoto 
et al. (1979). 
Induction of hCG-a and PAP by butyrate varied from one HeLa cell 
line to another (Fig I) and the degree of induction did not correlate 
with the constitutive production rate (Table 1). The difference in the 
fold induction among the cell lines probably does not result from a 
variation in their uptake and/or metabolism of butyrate. Uptake of 
butyrate was slower in HeLa 2.1 cells than in the other HeLa cell 
lines examined (data not presented), although the fold induction of hCG-a 
was comparable to Bela 2,2. This indicates that even though a lower 
amount of butyrate is incorporated by 2.1 cells compared to 2.2 cells, 
it is sufficiently metabolized to induce hCCHi to comparable levels in 
the two cell lines. These widely different rates o; constitutive pro­
duction and response to butyrate among the HeLa cell lines suggests that 
they may be useful in identifying factors controlling the expression of 
hCC-C and PAP. 
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In this report, the production of hCG-a and PAP activity in HeLa 
cells way «nl.ancud by bueyraee, bromodeoxyuridine» iododeoxyuridine, 
and thymidine. With each of these compounds, a lower concentration of 
inducer was required for maximum PAP induction than for maximum hCG-a 
induction (Figures tO and 13). The mechanism of induction by these 
compounds is unknown. The various effects of butyrate on cellular 
metabolism and possible effects on gene regulation were reviewed in the 
Introduction. With respect to the deoxynucleosides, some investigators 
have suggested that BrdUrd and IdUrd must be incorporated into the DMA 
in order to alter gene activity (Rutter et al., 1973; Bulmer et al , 
1976; Bick. l^ T'i, while others have disputed such a mechanism (Chou and 
Robinson. 1977a: Davidson and Kaufman. 1977; Cloz et al.. 1980). Since 
phosphorylation appears to be required for IdUrd action (Cos, 1974). 
deoxynucleosides, rather than the nucleosides, are most likely the 
active agents. The use, then, of cells deficient in thymidine kinase or 
other nucleoside metabolizing enzymes may be useful in determining the 
mechanism of action of these coo^ Knuds. 
The Iwiger period of incubation with BrdUrd, IdUrd, and Tbd than 
with butyrate needed to induce hCG-e and PAP implies that butyrate is 
more proficient than these deoxynucleosides (Fig 14). This may indicate 
that butyrate acts more directly on the expression of these proteins 
than the deoxynucleosides or that butyrate acts at multiple sites. The 
cytoplasmic dot bloc data (Fig. 19) demonstrated that the accumulation 
of hCC'a mRNA was enhanced in cells producing greatly elevated levels of 
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a-proc*in. The enhanced level of hCG-* transcripts may result from an 
increased rate of synthesis, a decreased rate of degradation, or a 
combination of these two processes. Since the dot blot hybridization 
reflects the level of transcripts at the time of cell harvest, it does 
not take into account earlier, possibly significant, transient fluxes. 
Such a transient flux of the mRNA has been reported for the induction of 
tyrosine aminotransferase by dibutyryl cAMP in rat livers (Xoguchi et 
al., 1982). Thus, it is difficult to compare directly the dot blot data 
with the hCC'a protein data which measures the 3 day accumulation of 
subunit in the medium. However, these data do show that certain 
conditions mediate the induction of hCG-e, in part, at the messenger 
level. Table XI shows that combining butyrate with IdUrd enhanced a 
protein 18.9 fold and a mRNA about 8.8 fold. Similar increases of the 
messenger and corresponding protein levels were observed in cells grown 
with Btr + BrdUrd, Btr * Thd, Btr * theophylline, and Btr * KU. This is 
in agreement with Darnell (1984) who observed chat butyrate enhanced the 
rate of transcription for hCG-a in HeW cells. Thus, the data presented 
in Table XI and Fig 20. along with Darnell (1984). indicate one site of 
butyrate action is on the a messenger levels. 
Another probable site of butyrate action is on the glycosylation of 
alpha subunit. The carboxylic acid enhances incorporation of 
glucosamine and fucose into the s subunits produced by Chang human 
liver cells (Morrow et al.. 1983) and by HeLa cells (Cox. 1981a: HcClure 
and Cox. 1984). Similarly, Firestone and Heath (1981) have suggested 
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that glycosylation is required for the induction of alkaline phosphatase 
by dibutyryl cAMP in mouse L cells. A dual effect on the same protein 
has been reported for dibutyryl cAftP which increased both the 
transcription and the translation of tyrosine aminotransferase in the 
rae liver (Noguchl et al., 1982). 
The synergism between butyrate and the deoxynucleosldes suggests 
that they are acting via different mechanisms (Table IV). While 
synergism was observed for the induction of hCG's but not PAP in this 
study. Park (1981) observed synergism for the induction of both 
proteins. This difference may reflect differences in the maintenance of 
stock cultures (spinner vs. monolayer), variations in the preparation 
and assay of cell extracts, and/or the use of different mediumi (MEM vs. 
RPMI 1640). The strongest and most consistent synergism wa# between 
butyrate and theophylline (Fig 11). While theophylline alone 
occasionally induced hCG-* to an extent similar to butyrate alone, the 
combination of these two agents consistently had a much greater than 
additive effect. This synergism involved a decrease in the lag between 
the addition of the effector and the onset of induction (Fig 12). The 
presence of a lag is consistent with an effect on protein production per 
se and not merely on the secretion of an intracellular pool of preformed 
subunit. A decrease in this lag may be due to a potentiation of 
transcriptional regulation and/or to post-transcriptional processes such 
as secretion. The first possibility is implied by the enhanced level of 
hCG-a mKNA (Figs 19, 20, and Table XI). The possibility of a primary 
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effect on the synthesis of a regulatory protein or of an enzyme (e.g. 
glycosyltransferase) involved in the expression of hCG-a or PAP cannot 
be ruled out. 
The effect of theophylline on hCG-a production is different from 
observations made by other groups. Kussa et al. (1977, 1978) found that 
dibutyryl cAMP and theophylline stimulated the eutopic production of hCG 
and subunits by normal term placenta and human malignant trophoblastic 
6 2 * 
cells vitro. The N - and 0 - monobutyryl derivatives of cAMP and 
the phosphodiesterase inhibitors, papaverine and 
3-isobutyl-l"methyl%anthine (IBMX), enhanced hCS secretion. However, 
these mediators of cAHP levels die not enhance the ectopic production of 
hCG or subunits in three non-trophoblastic cell lines: ClCo (established 
from a breast carcinoma and a producer of hCG-e), CaSki (established 
from a cervical carcinoma and a producer of hCG-8) and DoT (established 
from a spinal metastasis of a cervical carcinoma and a producer of 
hCG-@). Thus, HeLa cells differ from these other non-trophoblaatic cell 
lines in that theophylline alone stimulated hCIG-a production and was 
synergistic with butyrate (Table HI). 
Theophylline has been reported to inhibit constitutive PAP activity 
(Criffen et al., 1974) as well as that induced by IdUrd and 
hydrocortisone in HeLi cells (Wharton and Goz, 1979a). Wharton and Gos 
observed that caffeine and IBMX inhibited the induction of alkaline 
phosphatase with the order of potency being IBMX > theophylline > 
caffeine. These xanthine compounds decreased the heat stable form 
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relative eo the heac labile form. The inhibition reported by Grlffen 
W3H specific for theophylline and did not occur with either caffeine or 
xanthine. In addition, 1 mM theophylline inhibited partially purified 
PAP activity 50?«. but the enzyme was not appreciably inhibited by 
caffeine or xanthine. In another study, theophylline at 0.1 mM 
inhibited partially purified calf intestinal alkaline phosphatase by SOT. 
in an uncompetitive manner as well as human alkaline phosphatase 
activity in the sera of healthy individuals and patients with a variety 
of disorders (Fawaz and Tejirian, 1972). Fawaz and Tejirian did not 
observe an inhibition of alkaline phosphatase by caffeine or 
theobromine. Table III shows that xanthine compounds, in general, 
inhibited PAP activity in HeLa cells with a greater effect on induced 
than control activity. The relative potency was theophylline » caffeine 
> theobromine » xanthine. These results are consistent with the work of 
Wharton and Goz (1979a) but not with Griffen et al. (1974) or Fawaz and 
Tejirian (1972). The inconsistencies may be due to differences in 
species, isozyme, or HeLa cell strain. Although, the work of Fawaz and 
Tejirian indicates that theophylline can interact directly with alkaline 
phosphatase to inhibit activity, other mechanisms may be involved. For 
example, theophylline, as well as caffeine and adenine, inhibited the 
cAHP induction of tyrosine aminotransferase (TAT) in the IfTC rat 
hepatoma cell line by enhancing the rate of enzyme degradation 
(Stellwagen, 1974). 
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Although theophylline and other methylxanthines inhibit cyclic 
nucleotide phosphodiesterase, cAMP levels do not appear to be 
significant in the production of hCG-a and PAP activity. Figure 11 
shows that 1 cAMP alone did not induce hCG*a and in combination with 
I mM theophylline induced hCG*a about 4 fold. The magnitude of this 
stimulation does not appear to be sufficient to account for the 
synergism observed when theophylline is combined with butyrate. Whereas 
theophylline, caffeine, and theobromine inhibit phosphodiesterase, only 
theophylline enhanced the butyrate induction of hCG'S (Table III). 
Furthermore, butyrate had little effect on the level of cAMP (Table X>< 
Theophylline increased cAMP by about 1.7 fold and butyrate and 
theophylline about 1.8 fold. The lack of a significant change in cAMP 
may be due to measuring levels after prolonged exposure (72 hours) to 
these compounds. A significant, transient increase may have been 
observed if cAMP levels were monitored continuously after the addition 
of the effector(s). However. Hils et al. (1975) observed that after 24 
hours, 3 mM theophylline increased cAMP level* only about 1.6 fold even 
though phosphodiesterases in vitre as well as in intact cells were 
effectively inhibited. These authors suggest that most of the cAMP in 
Hela cells is strongly bound to specific proteins and thereby protected 
fror phosphodiesterases. In addition. Wharton and Cos (1979b) reported 
that treatment of HeW cells with I mM caffeine and theophylline for 72 
hours resulted in a slightly elevated and constant concentration of cAMP 
after the initial hour of exposure. While Wharton and Goz observed a 
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correlation between the inhibition of PAP activity and the concentration 
of cAMP. the inducers IdUrd and hydrocortisone did not alter the 
concentration of cAMP. Also, Hart et al. (1980) concluded that the 
parathyroid hormone (PTK) inhibition of the induction of alkaline 
phosphatase by IdUrd in KeLa cells was not mediated by cAMP. PTH did 
not alter adenylate cyclase activity even though PTH activates adenylate 
cyclase in bone and kidney. In addition, parathyroid extract did not 
potentiate the increase in cAMP by IBMX. The PTH data was interpreted 
to mean that either cAMP does not inhibit PAP activity or the mechanism 
of PAP inhibition differs between PTH and alkylxanthines. Since 
phosphodiesterases also hydrolyse cCMP, the concentration of this cyclic 
nucleotide may be important. 
Although the elevation in cAMP by alkylxanthines has been commonly 
attributed to its inhibition of phosphodiesterases, recent evidence 
suggests that the actual target may be the extracellular adenosine 
receptors to block the action of adenosine on adenylate cyclase (Daly et 
al., 19*1. Fredholm. 1980). 
2* 
Another action of methylxanthines is on cellular Ca homeostasis 
(Kopf et al,, 1984 and references therein). In this regard, it is of 
2"fr interest that the influx of Ca in HeLa cells is stimulated by PTH 
(Borle, 1968) and IBMX (Friedman et al,, 1976), compounds which also 
inhibit alkaline phosphatase induction in HeLa cells (Hart et al., 
1980). It was also reported by Hart et al. (1980) that the calcium 
ionophore A23187 at about 1 wM significantly inhibited the IdUrd 
induction of alkaline phosphatase. 
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Although cna mechanism by which xanthine compounds lower PAP 
activity is not understood, possible factors include cAMP, adenosine, 
2+ 
Ca , and/or a direct interaction with the enzyme. A concentration 
study may differentiate between effects on phosphodiesterase and 
adenosine receptors since the latter is effected by micromolar 
concentrations while the former requires millimolar levels (Daly et al.. 
1981, Londos et al., 1981). It would also be of interest to examine the 
effect of IBMX on butyrate induction. While Wharton and Goz (1979b) 
observed a correlation between cAMP levels and the inhibition of 
alkaline phosphatase activity, a mechanism connecting these two events 
has not been delineated. Also, the lack of effect on cAMP levels by 
PTH, IdUrd, and hydrocortisone argue against a cAMP mediated regulation 
of alkaline phosphatase activity. The role of Ca or adenosine in PAP 
activity has not been studied. 
Deoxycytidine inhibited the induction of hCG-o and PAP by a number 
of compounds (Table IV), although the the data presented in Fig 15 
suggest that the butyrate induction of hCG-e may be less sensitive. 
These data extend the observations of Goz ee al. (1980) that dCyd 
inhibits the induction of PAP by IdUrd, hydrocortisone, butyrate, and 
choline chloride and are the first report of its inhibition of a subunit 
induction. In addition. Davidson and Kaufman (1977) reported that dCyd 
reversed tne suppression of pigmentation in Syrian hamster melanoma 
cells by BrdUrd. Both Cos et al. (1980) and Davidson and Kaufman (1977) 
suggest that dCyd does not alter gene expression by interfering with 
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overall incorporation of IdUrd or BrdUrd into the DNA, although 
incorporation into specific regions may be relevant. 
The effect of dCyd on the induction of hCG-a and PAP by butyrate 
suggests that dCyd interferes with an early event of butyrate induction. 
Once butyrate initiates this process, it cannot be reversed by dCyd (Fig 
17). The greater sensitivity of PAP induction to dCyd is consistant 
with the concept that PAP and hCO-a are not co-ordinately regulated. 
Furthermore, it suggests that dCyd interferes with a process more 
closely associated with the induction of PAP than the induction of 
hCG-o. While dCyd had a preferential inhibition of PAP induction, dGuo 
and possibly dAdo inhibited the butyrate induction of both PAP and hCG-a 
(Table VIII). The relative potencies of the deoxynucleosides to inhibit 
induction was dGuo > dAdo » dCyd. Thymidine was unique in that it 
either had no effect on butyrate induction (PAP) or was synergistic with 
butyrate (hCG-a). 
Taken together, these data suggest that nucleosides or nucleotide 
compounds may be involved in regulating the expression of hCG-* and PAP. 
Although the mechanism is unknown, there are several possible sites of 
action. The incorporation of deoxynucleoside analog* (IdUrd or BrdUrd) 
into the DNA may alter the binding of proteins which regulate gene 
transcription. BrdUrd-substituted DNA has been demonstrated to result 
in a tighter binding of the lac repressor protein (Lin and Riggs, 1971, 
1972) and other proteins (Gordon et al., 1976). Bick (1977) reported 
that dCyd expanded the intracellular pool of TIP which decreased the 
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incorporation of BrdUrd into DNA, thereby reversing the inhibition by 
BrdUrd of the butyrate-mediated differentiation of Friend murine 
leukemia cells. 
However, other mechanisms are also possible. For example. BrdUrd 
induces prolactin synthesis in OH cells via gene amplification (Biswas 
and Hanes. 1982) of an extra chromosomal element (Wilson et al.. 1983). 
Also, the inhibition of pigmentation in melanoma cells by BrdUrd appears 
to involve a mechanism independent of its incorporation into DNA 
(Davidson and Kaufman, 1977)< Furthermore, dCyd inhibits the induction 
of PAP by hydrocortisone, bucyrace, and IdUrd in HeLa cells (Cos et al.. 
1980). While dCyd may be affecting the incorporation of IdUrd into DNA. 
this explanation does not account for its inhibition of induction by 
butyrate and hydrocortisone. Recently, hydroxyurea, a long-established 
inhibitor of ribonucleotide reductase, has been shown to inhibit the 
degradation of internalized epidermal growth factor (Hasuda et al.. 
1982). The data of Chou and Robinson (1977a). Davidson and Kaufman 
(1977), and 6oz et al. (1980) indicate that the free forms of the 
daoxynucleosides alter gen# expression, suggesting that deoxynucleotide 
pool sizes nay be important. 
Deoxynucleotide pool imbalances are known to be mutagenic in 
mammalian cells presumably by decreasing the fidelity of DNA replication 
(Meuth et al., 1979; Weinberg et al., 1981; Kunkel et al., 1982; 
Peterson et al., 1983). In the present study, butyrate decreased the 
pool sizes of dATP and TTP. Also, Dexter et al. (1981) observed that 
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bucyracd, as well as N,N-dim«chyl(ormamid*, modulated the accivieies of 
purine mecabolizing enzymes in cultured human colon carcinoma cells in a 
cell-type dependent manner. For example, bueyrace increased the 
activity of adenosine deaminase about 5 fold in KCT-15 cells but 
decreased the activity of the enzyme about 2 fold in cells of DLD-1 
clone A. Depletion of a key nucleotide may inhibit DMA synthesis and 
synchronize the cell population at the Qt/S border. Many of the 
inducers have been characterized to synchronize cells near the Cl/S 
border. If active genes are preferentially replicated early in S 
(Kajiwara and Mueller. 1964. Furst et al., 1981). such a cell cycle 
block nay enhance the accessibility of the gene to RNA polymerase. 
Evidence for a relationship between the tim# of replication and gene 
activity has been reviewed by Taylor (1984). However, Darnell (1984) 
has demonstrated that butyrate induces the transcription of hCG-a 
independent of the position of the cell in the cell cycle. Also, the 
inability of butyrate to induce the eutopic production of hCG'tt appears 
inconsistent with a cell cycle related mechanism. All of the 
deoxynucleosides inhibited DRA synthesis and tha combination of 
effectors inhibited DNA synthesis to a greater extent than an individual 
effector by itself. The apparent lack of correlation between the degree 
of DNA synthesis inhibition and the strength of induction see» 
inconsistent with the idea that these two events are dependent on each 
other. 
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While ch«s« various roporcs relate deoxynucleosides to OSA 
synthesis, deoxynucleoside analogs may alter processes involving 
nucleotides which are unrelated to DNA replication as illustrated by the 
recent identification of a cytosine arabinoside nucleotide sugar 
compound in celts grown in 3 wM cytosine arabinoside (Lauzon et ai.. 
1978a, Lauzon et at., 1978b}. Thus, one possibility would be an effect 
of deoxynucleosides on nucleotide sugars which are involved in membrane 
and glycoprotein biosynthesis. It is interesting that butyrate 
Î4 inhibited the incorporation of exogenous |C| choline (Fig 18). This 
inhibition may result from a dilution of the label due to enhanced 
phosphatidyl choline synthesis (via CDP-choIine) or degradation of 
choline containing compounds, an inhibition of the uptake of exogenous 
choline, or a demethylation of choline which would remove the 
radiolabel. 
Several pieces of information make an effect on nucleotide sugars 
attractive; I) induction is inhibited by deoxynucleosides at 2 mM but 
not at 100 wM, while micromolar concentrations of exogenous 
deoxynucleosides significantly alter deoxynucleoside triphosphate levels 
in human T lymphocytes (Cohen et al,, 1983), 2) lack of a stringent 
correlation between induction and the inhibition of DMA synthesis. 3) 
the role of nucleotide sugars in the glycosylation of glycoproteins 
and the biosynthesis of membrane components. 4) methotrexate and FdUrd 
appear to expand the dlTT? pools by inhibiting thymidylate synthetase 
resulting in the formation of dUDP-GlcKAc in lymphoid cells, and a 
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compound synthesized by cells created with Fdtlrd has been tentatively 
identified as S-FdUDP-GlcNAc (Peterson et al.. 1983), S) the modulation 
of alkaline phosphatase activity by choline, lysophosphatidyl choline, 
and Rosenthal's Inhibitor, suggesting that the membrane composition 
may be important in regulating alkaline phosphatase activity (Hung and 
Melnykovych. 1976; Melnykovych and Lopes. 1977), 6) the many membrane 
associated changes induced by butyrate, and 7) the previously 
mentioned significance of glycosylation to the induction of hCG-a by 
butyrate (Morrow et al.. 1983; Cox. 1981a; McClure and Cox. 1984) and of 
PAP by dibutyryl cAMP (Firestone and Heath, 1981). 
A correlation between hypomethylation of ONA and gene activity, in 
general. has been suggested by others and has been reviewed bf Doerfler 
(1983) and Bird (1984), Recently, methylacion of the hC6-o gene was 
examined in DMA isolated from HeLa 2,1 (a low g producer). HeLa 2,2 (a 
high producer), and human placenta using the restriction endoculeases 
Hpa II and Msp I and a radiolabelled a-cDNA probe. Both enzymes 
recognize the four base sequence of 5'«CC(jC*3'. but Hpa II does not 
cleave the ONA when the internal cyeosine is methylated whereas Msp I will 
cut regardless of methylacion. This experiment revealed that the s gene 
is methylated to a greater extent in 2.1 OKA than in 2.2 DMA and further 
suggested that the gene structure of a in HeLa OKA differed fr.m the 
normal placental gene (Clare Kenney and G. Stanley Cox, Dept. of 
Biochem., U. of Neb. Med. Center, Omaha, NE, personal comnamication). 
Thus, the difference in the rate of a production among the HeLa cell 
lines may be explained, at least in part, by the degree of methylation 
of the alpha gene. 
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The data presented in this study may be explained by effects of 
butyrate and the deoxynucleoside inducers on transcription and 
glycosylation but via different mechanisms. For example, the 
modification of chromatin proteins (acetylation, phosphorylation, ADP-
ribosylation) mediated by butyrate CBoffa et al., 1981) probably affects 
their binding to DNA and alters the chromatin structure resulting in 
enhanced gene activity. However. deoxynucleoside inducers may act by 
changing the base composition of the DNA. either by incorporation of the 
modified nucleoside itself or by protmting misincorporâtion. which could 
alter protein binding and chromatin structure leading to gene 
activation. At the level of glycosylation. butyrate could alter the 
level of enzyme or modify the activity of glycosyltransferases such as 
sialyltransferase I (Fishman et al,, 1974) or galactosyltransferase 
(C. Stanley Cox. unpublished observations). Deoxynucleoside# may also 
change the activity of glycosylation enzymes, perhaps as a result of 
either presenting the enzyme with a modified substrate (deoxynucleotide 
instead of ribonucleotide sugar) or possibly acting directly as a 
positive or negative modulator. 
This mechanism could explain the time course of induction data in 
Fig 14 since changes in the chromatin structure resulting fros protein 
modification would presumably occur faster than those rssulting from 
alteration in the base coeqtositionv Since different mechanisms are 
involved, the combination of butyrate with a deoxynucleoside inducer may 
be synergistic. Also, deoxycytidine appeared to be a stronger 
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antagonist of the deoxynucleoside inducers than of butyrate (Table IV). 
In this case, deoxycytidine may alter pool sizes to preferentially 
counter the deoxynucleoside effects. 
A number of experiments could be designed to test this hypothesis. 
I) As an initial experiment it would be beneficial to use specifically 
labelled compounds to determine how the deoxynucleosides are metabolized 
(phosphorylation, dehalogenation, base replacement by salvage pathway 
enzymes). 2) Look for incorporation of the deoxynucleoside inducer into 
the DNA using radiolabelled precursor incorporation into TCA 
precipitable material of purified DNA and/or determination of the ONA 
base composition. 3) Look at the incorporation into DNA as a function 
of inducer concentration and time course on induction. 4) Examine the 
incorporation of radiolabelled precursors into the a gene region by 
hybridization to e-cDNA. 5) If the chromatin structure is altered to 
increase the accessibility of the s gene to transcription proteins, this 
may be detected by following the kinetics of nuclease digestion of this 
region. 6) Monitor the activity of glycosylation enzymes with the time 
course of induction. 7) Examine the rate of glycosylation of e and PA? 
in the presence of various inducers. 8) Study the half-life and rate of 
secretion or transport of a and PAP in relation to induction. 9) If the 
incorporation of the halogenated deoxyuridine compounds into DWk is 
required for induction, then dCyd would not be expected to block 
induction in those cells preincubated with the inducer. A partial or 
complete inhibition may be expected if the site of action is 
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glycosylation where dCyd would still presumably generate a competing 
compound. 
The data in this study also suggest that the expression of hCG-a 
and PAP in KeLa cells are not co-ordinately regulated. This conclusion 
is supported by the lack of correlation between the two genes in 
numerous HeLa cell lines with regard to constitutive and butyrate 
induced synthesis (Table !. Fig 1). the difference in inducer 
concentration which stimulated their maximum production (Fig 10 and 13). 
the synergism observed between butyrate and other inducers for the 
induction of hCG*a but not PAP (Table IV), the Inhibition of PAP 
induction but not hCG-a induction by xanthine compounds (Table Illj. and 
the observation that the butyrate induction of PAP activity is more 
sensitive to dCyd than the induction of hCC-a (Fig 15). 
Since the study of PAP induction involved the measurement of 
activity, it is not known if the observed effects are on the synthesis 
of protein or the catalytic efficiency of the enzyme. The delay in 
induction (Fig 14) along with the reports of Hamilton and Sussman (1981) 
and Ito and Chou (1984) argue for increased synthesis. If regulation of 
gene expression is restricted to the transcriptional level, the 
discordant expression of these proteins io^ ilies that there may be a 
difference in the chromatin organization or promoter strength of these 
genes (Veisbrod, 1982). Perhaps a difference in chromatin proteins 
associated with each gene or distribution of specific bases within each 
gene or near control sequences could result in different sensitivities 
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CO th« same inducer. If a posc-cranscriptional effect is being 
observed, the discordant regulation may then be related to the 
difference in the fate of each protein. I.e., secretion for O or 
insertion into the plasma membrane for PAP. Although most evidence 
indicates that secretion and transport of plasma membrane proteins to 
the surface occur via the same pathway, Gumbiner and Kelly (1982) 
suggest that in some instances these two processes may diverge. It is 
also possible that the primary action of the inducers is on a membrane 
component which alters PAP activity (such as phosphytidylcholine). 
Membrane composition has been shown to be important to the activity of 
other membrane enzymes (Merisko et al.. 1981; Galo et al.. 1981; 
Hegyvary et al.. 1980). 
As part of a continuous project, this study indicates that 
deoxynuclcosides may be useful in determining processes important to 
hCC-a production and PAP activity in HeLa cells and perhaps to gene 
expression in general. In this regard, mutants of deoxynucleoside 
metabolism; may help determine which metabolites are significant. Also, 
the possibility of multiple effects by some of these agents does not 
seem unreasonable. Further experiments are needed to better understand 
the action of these compounds on gene expression. 
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